gene	Cytoband			Homozygous/heterozygous	Sample ID	PubMed ID	methods of detecting mutation（sanger、WES、WGS、target-sequenceing）	国家	人群	性别:F/M	AAO	Result of functional study:U/Y/N （文献）	动物/细胞实验验证:（U/C/A）		subtype of disease	 sporadic/pedigree
PRKN	6q26	Exon 3	deletion	homozygous	III1	11215581	PCR analysis	China	Asian	U	U	N	U	Familial Parkinsonism	"presented with relatively mild parkinsonism; showed marked response to levodopa with a relativelylow dosage of levodopa (300 to 400 mg daily). However, remarkable levodopa-induced dyskinesia was observed"	pedigree
PRKN	6q26	Exon 3	deletion	homozygous	III2	11215581	PCR analysis	China	Asian	U	U	N	U	Familial Parkinsonism	"presented with relatively mild parkinsonism. In addition, mild foot dystonia, i.e., plantar flexion of toes and equinovarus posture of the feet, was observed; showed marked response to levodopa with a relativelylow dosage of levodopa (300 to 400 mg daily). However, remarkable levodopa-induced dyskinesia was observed"	pedigree
PRKN	6q26	Exon3-4 	deletion	heterozygous	II-1	11459900	sanger	Japanese	U	F	38	U	U	Autosomal recessive juvenile parkinsonism(AR-JP) 	"Parkinsonian symptoms, including bradykinesia and rigidity, were prominent, but restingtremor was not noted in any of the threepatients. Horizontal gaze evoked nystagmus,limb ataxia, and postural tremor were seen.Deep tendon reflexes, including jaw jerk, weremoderately exaggerated, but there was no Babinski's sign. "	pedigree
PRKN	6q26	Exon3-4 	deletion	heterozygous	II-2	11459900	sanger	Japanese	U	M	34	U	U	Autosomal recessive juvenile parkinsonism(AR-JP) 	"Parkinsonian symptoms, including bradykinesia and rigidity, were prominent, but restingtremor was not noted in any of the threepatients. Horizontal gaze evoked nystagmus,limb ataxia, and postural tremor were seen.Deep tendon reflexes, including jaw jerk, weremoderately exaggerated, but there was no Babinski's sign. "	pedigree
PRKN	6q26	Exon3-4 	deletion	heterozygous	III-1	11459900	sanger	Japanese	U	M	37	U	U	Autosomal recessive juvenile parkinsonism(AR-JP) 	"Parkinsonian symptoms, including bradykinesia and rigidity, were prominent, but restingtremor was not noted in any of the threepatients. Horizontal gaze evoked nystagmus,limb ataxia, and postural tremor were seen.Deep tendon reflexes, including jaw jerk, weremoderately exaggerated, but there was no Babinski's sign. "	pedigree
PRKN	6q26	Exon3-5		compound heterozygotes	RM611	11561042	semiquantitative multiplex polymerase chain reaction (PCR) protocol and haplotype analysis				35	U	U	autosomal recessive early onset parkinsonism	"Our examination in 1998 (at age 76, after 40years of disease course) showed a flexedposture, axial akinesia and gait diYculties;moderate generalised rigidity, and mild diVusebradykinesia in all four limbs, although moresevere in the upper limbs and on the left side.Tremor was absent and the tendon reflexeswere normal. Dysarthria and hypomimia weremild, and a Meyerson's sign was present. Cognition was normal and there was no severeautonomic disturbance. His on state Hoehnand Yahr stage was III. Brain MRI was normal.He was still treated with oral lisuride (0.5 mgfour times/day) and deprenyl (5 mg/day)"	pedigree
PRKN	6q26	Exon 3-9	deletion	U	RM612	11561042	semiquantitative multiplex polymerase chain reaction (PCR) protocol and haplotype analysis					U	U	autosomal recessive early onset parkinsonism	" Tremor was bilateral, although moresevere on the right side. When bradykinesiaand rigidity developed later, she was diagnosedwith Parkinson's disease. The disease wasslowly progressive, aVecting both sides of thebody, although more severely on the right side.In the late 1960s, after more than 25 years, thesymptoms had worsened to the extent that sheunderwent stereotactic left thalamotomy,which satisfactorily controlled the contralateralJ Neurol Neurosurg Psychiatry 2001;71:531-534 531Department ofNeurological Sciences,'La Sapienza University, Rome, ItalyV BonifatiE FabrizioG MecoINSERM U289,Hospital, Paris,FranceCB to: Department of Clinical Genetics, Room2430, Erasmus UniversityRotterdam, Post OYce Box1738, NL-3000 DRRotterdam, The Netherlandsbonifati@kgen.fgg.eur.nlReceived 24 October 2000and in final form25 April 2001Accepted 14 May 2001www.jnnp.comtremor. She was treated with levodopa from1970, with good response. After several yearsshe developed motor fluctuations and levodopainduced dyskinesias. We were able to examineher at the age of 89, after 58 years of diseasecourse, a few months before her death; she hada severe akinetic rigid syndrome, with Hoehnand Yahr stage IV in the on, and V in the oVstates, respectively. Only mild resting tremorwas evident in both upper limbs. Tendonreflexes were brisk. She also had a memorydeficit, visual hallucinations, and frank confusional episodes, which were reported to havebeen present during the past 3 years."	pedigree
PRKN	6q26	Exon3 	deletion	homozygous 	EP11-1	12056932	sanger	 Spanish	U	F	U	U	U	U	U	pedigree
PRKN	6q26	Exon3 	deletion	homozygous 	EP11-4	12056932	sanger	 Spanish	U	M	U	U	U	U	U	pedigree
PRKN	6q26	Exon3 	deletion	homozygous 	EP11-5	12056932	sanger	 Spanish	U	F	U	U	U	U	U	pedigree
PRKN	6q26	Exon5 	deletion	homozygous 	EP18-1	12056932	sanger	 Spanish	U	M	U	U	U	U	U	pedigree
PRKN	6q26	Exon8-9 	deletion	heterozygous	EP13-3	12056932	sanger	 Spanish	U	M	U	U	U	U	U	pedigree
PRKN	6q26	Exon1 	deletion	Heterozygous	IT15 RM513	12116199	semi-quantitative multiplex PCR	U	U	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon7-9	deletion	Heterozygous	IT-021-007	12116199	semi-quantitative multiplex PCR	U	U	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon5 	deletion	Heterozygous	FPD-064-01	12116199	semi-quantitative multiplex PCR	U	U	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon3 	deletion	Heterozygous	SAL-431-011	12116199	semi-quantitative multiplex PCR	U	U	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon5 	deletion	Heterozygous	SAL-431-011	12116199	semi-quantitative multiplex PCR	U	U	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon8 	deletion	Heterozygous	UK103	12116199	semi-quantitative multiplex PCR	U	U	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon2 	duplication	Heterozygous	SPD-134-010	12116199	semi-quantitative multiplex PCR	U	U	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon4 	duplication	Heterozygous	SPD-134-010	12116199	semi-quantitative multiplex PCR	U	U	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon4-7	deletion	Heterozygous	FPD-227-007	12116199	semi-quantitative multiplex PCR	U	U	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon 3	deletion	Heterozygous	IT63 RM641	12116199	semi-quantitative multiplex PCR	U	U	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon5-6	deletion	homozygous 	PK-205	12397156	sanger	 Spanish	U	F	27	U	U	U	U	pedigree
PARK7	1p36.22	 intron 5	deletion	homozygous	12446870-1	12446870	PCR analysis	Dutch	Dutches	U	U	N	U	Early-Onset Parkinsonism	U	pedigree
PRKN	6q26	Exon 2-3 	deletion	U	Mutation-3 (2 families)	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	"Exon 2, 3-4 "	 duplication	U	Mutation-4	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon3 	 duplication	U	Mutation-5	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 3-4 	deletion	U	Mutation-8 (4 families)	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 4 	deletion	U	Mutation-10	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 4-6 	deletion	U	Mutation-11	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 5 	deletion	U	Mutation-12 (4 families)	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 6 	deletion	U	Mutation-15 (2 families)	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 7 	duplication	U	Mutation-17	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 7 	deletion	U	Mutation-19	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 8 	deletion	U	Mutation-20 (12 families)	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 8 	duplication	U	Mutation-21 (6 families)	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 8-9 	deletion	U	Mutation-22	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 10 	duplication	U	Mutation-23	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 10 	deletion	U	Mutation-24 (4 families)	12629236	Fluorescent dosage PCR	North American	U	U	U	U	U	Families with at least two siblings with PD	"Mutations in the parkin gene occur among individuals with PD with an older age at onset ( 60 years) who have a positive family history of the disease. In addition, the clinical findings of parkin-positive individuals are remarkably similar to those without mutations"	pedigree
PRKN	6q26	Exon 4 	deletion	homozygous 	II-3	12728478	semiquantitative PCR assay and direct sequencing of the coding region	Korean	U	F	44	U	U	AR-JP	"The clinical course was very slow, has motor fluctuations"	pedigree
PRKN	6q26	Exon 4 	deletion	homozygous 	II-4	12728478	semiquantitative PCR assay and direct sequencing of the coding region	Korean	U	F	38	U	U	AR-JP	"The disease progressed slowly, affecting both sides of the body;at the age of 47, she showed only mild dysarthria."	pedigree
PRKN	6q26	Exon 4 	deletion	homozygous 	II-5	12728478	semiquantitative PCR assay and direct sequencing of the coding region	Korean	U	M	34	U	U	AR-JP	"paresthesia of the lower extremities,and a twisting sense in the left toe"	pedigree
PRKN	6q26	Exon 3  	deletion	Heterozygous	SPD-145-012	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	12	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 2-4	duplication	Heterozygous	SPD-134-10a	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	30	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon3 	deletion	Heterozygous	SPD-134-10a	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	30	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 3-4  	deletion	Heterozygous	SPD-146-005	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	35	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 6  	deletion	Heterozygous	SPD-164-10	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	27	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 2  	deletion	Heterozygous	SPD-169-003b	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	29	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon3  	deletion	Heterozygous	SPD-169-003b	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	29	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 3 	deletion	Homozygous	JMP28	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	Italy	Caucasian	U	28	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 3-5  	deletion	Heterozygous	BHAM 18c	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	UK	Caucasian	U	18	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 6 	duplication	Heterozygous	SPD-099-003	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	Italy	Caucasian	U	28	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 3-4  	deletion	Heterozygous	SPD-110-001a	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	Algeria	Caucasian	U	34	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 10  	deletion	Heterozygous	SPD-112-001	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	36	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 3  	duplication	Heterozygous	SPD-123-007	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	30	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 2  	deletion	Heterozygous	SPD-166-010b	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	45	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 3-4  	deletion	Heterozygous	SPD-166-010b	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	45	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 4  	deletion	Heterozygous	SPD-181-009	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	27	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 3-4  	duplication	Heterozygous	SPD-187-003c	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	France	Caucasian	U	29	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 2-3  	duplication	Heterozygous	SPD-245-001c	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	Brazil	Caucasian	U	43	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	Exon 2-4  	deletion	Heterozygous	JMP 37	12764050	semi-quantitative polymerase chain reaction combined with sequencing of the entire coding region	Italy	Caucasian	U	7	N	U	Early-Onset Parkinsonism	U	sporadic
PRKN	6q26	40 bp  in Exon 3	deletion	homozygous 	12781599-1	12781599	sanger	US	Caucasians	M	24	U	U	U	The patient with this mutation proved to be a member of the only family with a dominant pattern of inheritance.	pedigree
PRKN	6q26	Exon4-5 	deletion	homozygous 	Patients II-1 from Family 2	12889082	semiquantitative PCR assay and direct sequencing of the coding region	Russian	U	F	32	U	U	AR-JP	levodopa-induced dyskinesias after 1 month of treatment	pedigree
PRKN	6q26	Exon4-5 	deletion	homozygous 	Patients II-1 from Family 4 	12889082	semiquantitative PCR assay and direct sequencing of the coding region	Russian	U	M	12	U	U	AR-JP	Decreased tendon reflexes	pedigree
PRKN	6q26	Exon3-7 	deletion	heterozygous	Patient II-6 from Family 3	12889082	semiquantitative PCR assay and direct sequencing of the coding region	Russian	U	M	17	U	U	AR-JP	"Mild Cognitive decline, CT or MRI imply  Mild dilatation of the cerebral subarachnoidal space, levodopa-induced dyskinesias after 216 month of treatment"	pedigree
SNCA	4q22.1	SNCA	triplication 	heterozygous	U	14593171	RT-PCR	U	U	U	60	N	N 	typical PD	U	pedigree
SNCA	4q22.1	SNCA	triplication 	heterozygous	U	14593171	RT-PCR	U	U	U	77	N	N 	typical PD	U	pedigree
PARK7	1p36.23	Exon 1-5	deletion	Homozygous	14598065-1	14598065	"Microsatellite markers analysis, cloning, PCR, sequencing"	Dutch	Dutch	U	U	N	U	EOPD	U	pedigree
PRKN	6q26	E4-E6	deletion	U	U	14714215	U	Israel	U	M	29;25	N	U	EOPD	"Our patients with parkin mutation performed poorly on neuropsychological tests compared to those with YOPD.the older and younger brothers have developed parkinsonian signs at age 25 and 29 with mild tremor as well as rigidity. Both have responded significantly to levodopa treatment but developed motor response fluctuations and dyskinesia after few years of treatment. This clinical course was remarkable for severe freezing in the older brother and festination in the younger one. The older brother have developed slowly over a course of two to three years some psychiatric delusions and later a functionally significant dementia. A full work up for other causes of dementia like vascular changes, endocrine or metabolic disturbances was negative. The younger brother had no signs of any cognitive disturbances from the functional point of view neither psychotic features. The two patients have a sister and two brothers, who have no signs of any neurological or neurobehavioral disturbances. Similarly, no other family members had any neurological or neuropsychiatric disorders diagnosed."	pedigree
SNCA	4q22.1	Exon 2-3	duplication	U	Branch J	14755720	qPCR; Microsatellite markers analysis; Affymetrix 250K microarray	Sweden	Sweden	F	71	N	U	LOPD	U	pedigree
SNCA	4q22.1	Exon 2-3	triplication	U	Branch I	14755720	qPCR; Microsatellite markers analysis; Affymetrix 253K microarray	United States	Sweden	M	31	N	U	EOPD	U	pedigree
PARK7	1p36.23	Exon 5-7	deletion	Heterozygous	B-66	14872018	Quantitative duplex PCR	Caucasian	Caucasian	M	42	N	U	EOPD	U	sporadic
PARK7	1p36.23	Exon 5-7	deletion	Heterozygous	L1347	14872018	Quantitative duplex PCR	Caucasian	Caucasian	F	17	N	U	EOPD	U	sporadic
PARK7	1p36.22	c.253_322	deletion	heterozygous	15108293-2	15108293	dHPLC analysis/gene dosage studies	Serbian	Europe	M	52	N	U	LOPD	"He developed loss of dexterity of the right armat the age of 45 years. The disease progressed quickly and became symmetrical 2.5 years after symptom onset. Thepatient died of myocardial infarction at the age of 53 years;On neurologicalexamination at age 52 years, he showed hypomimia, slurred speech, bilateral akinesia and rigidity, also affectingaxial muscles, a parkinsonian gait with postural instability and falls;"	sporadic
PARK7	1p36.23	Exon 5	deletion	Heterozygous	case 2	15108293	qPCR	Serbian	Serbian	M	45	N	U	EOPD	U	sporadic
PRKN 	6q26	c.836_972	deletion	heterozygous	15108293-1	15108293	SSCP/dHPLC/sequencing	Serbian	Europe	M	44	N	U	LOPD	"He presented with a three-year history ofdifficulties writing, followed by a feeling of slowness and stiffness of the right hand;On neurological examination, he showed hypomimia, unilateral mild bradykinesia confined to the rightbody half, and rigidity"	sporadic
PRKN	6q26	Exon 4	deletion	homozygous	479-10  	15254940	TaqMan/Sanger	Turkey	Turkish 	M	16	N	U	typical PD	Parkinson's disease 	pedigree
PRKN	6q26	Exon 4	deletion	homozygous	479-6	15254940	TaqMan/Sanger	Turkey	Turkish 	F	36	N	U	typical PD	Parkinson's disease 	pedigree
PRKN	6q26	Exon 4	deletion	homozygous	479-8	15254940	TaqMan/Sanger	Turkey	Turkish 	F	28	N	U	typical PD	Parkinson's disease 	pedigree
PRKN	6q26	Exon2-4 	deletion	homozygous	15315343-1	15315343	PCR Amplification	china	Asia	F/M	U 	N	U	EOPD	"bradykinesia, tremor, postural instability andmuscular rigidity"	pedigree
SNCA	4q22.1	"Exon 3, 4"	triplication	U	15451224-1	15451224	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 250 K microarray"	France	France	U	U	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	duplication	U	15451224-2	15451224	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 251 K microarray"	France	France	U	U	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	duplication	U	15451224-3	15451224	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 252 K microarray"	France	France	U	U	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	duplication	U	15451224-4	15451224	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 253 K microarray"	France	France	U	U	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	duplication	U	15451224-5	15451224	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 254 K microarray"	France	France	U	U	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	duplication	U	Patient 1	15451225	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 255 K microarray"	France	France	F	50	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	duplication	U	Patient 2	15451225	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 256 K microarray"	Italy	Italian	F	46	N	U	U	U	pedigree
PRKN	6q26	Exon4-6	deletion	 homozygous 	1006	15852366	qPCR	Israel	Persian Jewish	M	19	N	U	AR-JP	"At age 32, He had fatigue and excessive sweating, head and limb tremor (more on the left side of the body), mild rigidity, and marked retropulsion. At that time, L-dopa treatment was initiated. Three years later motor fluctuations, dyskinesias, and dystonia of the right foot emerged. The patient presented intolerance to carbidopa and responded to very low doses of L-dopa (200 mg/day). The parkinsonian symptoms progressed slowly, but 31 years after disease onset, he became very disabled due to freezing gait with recurrent falls. On his recent examination, he was still taking very low doses of pure L-dopa (50 mg q.i.d), selegiline 5 mg/day, trihexyphenidyl 5 mg/day, and amantadine 200 mg/day. On examination while on, the patient had hypomimia, dysarthria, no tremor, mild rigidity in all extremities, was able to arise from chair with assistance, and gait was impaired with freezing episodes and postural instability. While off, he had marked hypomimia, rigidity, and bradykinesia of all four limbs, and he was almost akinetic, with severe andfrequent freezing episodes."	pedigree
PRKN	6q26	Exon4-6	deletion	 homozygous 	1005	15852366	qPCR	Israel	Persian Jewish	F	21	N	U	AR-JP	"Eleven years from disease onset, low doses of L-dopa were initiated with very good response. During the course of the disease there were diurnal variations without sleep benefit, as she felt worse in the morning hours. Her symptoms included fatigue, weight loss, excessive sweating, and pain on the right hand. On her last examination, the most prominent symptom was rest and postural tremor of all extremities and increased tonus more on the right side of the body. Hand and leg movements were normal. She had no difficulties rising from a chair, and there was no gait abnormality."	pedigree
PRKN	6q26	Exon4-6	deletion	 homozygous 	1084	15852366	qPCR	Israel	Persian Jewish	F	18	N	U	AR-JP	"On her first examination (she was 28 years old), the patient had hypomimia, rest tremor in allextremities and in the tongue, mild rigidity, and bradykinesia in all limbs. Treatment with anticholinergic agents was initiated with beneficial response. 37years old, she started treatment with L-dopa/carbidopa (125mg/day) with marked response. At the age of 38, she developed oral and limb dyskinesias. until present, is treated with pure L-dopa (100 mg/day). Other medications are selegiline 5mg/day, and trihexyphenidyl 5 mg/day.At the time of her most recent examination, she had marked difficulties with walking, severe freezing gait, marked rigidity, and dyskinesias of the left foot."	pedigree
PRKN	6q26	Exon4-6	deletion	 homozygous 	1064	15852366	qPCR	Israel	Persian Jewish	M	39	N	U	AR-JP	"The patient started treatment with trihexyphenidyl with good response. During the first years of the disease, have depression and anxiety. Twelve years after disease onset, he complainedof migrating pain in body,constipation, depression, and insomnia. He also could not tolerate carbidopa and was treated with low doses of L-dopa (100 mg/day) with moderate response. He remained stable over the course of 10 years and even stopped taking L-dopa, as he felt worsening of his symptoms (pain, tremor, general weakness) under all the L-dopa preparations. He was treated only with trihexyphenidyl and selegiline 5 mg/day. The most prominent symptoms were psychiatric, with psychomotor restlessness,marked anxiety, akathisia, and unexplained fears."	pedigree
PRKN	6q26	E2-E4	triplication 	 homozygous 	Family N1-brother1-patient1	15862897	Semi-quantitative multiplex PCR	Asturias Spain	Spanish	M	41	N	U	EOPD	"Patient 1 initially presented with symptoms of foot dystonia at 41 years. After a disease of 24 years he suffers parkinsonism with severe freezing but maintains an excellent response to l-DOPA therapy with moderate dyskinesias. His Hoehn and Yahr score is 3 on/5 off. He has some evidence of cognitive impairment and psychiatric symptoms, including behavioral disorder, a phenotype consistent with loss of parkin function and disease of long duration."	pedigree
PRKN	6q26	E2-E4	triplication 	homozygous	Family N1-brother2-patient4	15862897	Semi-quantitative multiplex PCR	Asturias Spain	Spanish	M	46	N	U	EOPD	"Patient 4 presented at 46 years with bradykinesia and has suffered a milder course. After a disease of 18 years his Hoehn and Yahr score is 3 on/4 off; he maintains an excellent response to l-DOPA albeit with moderate freezing and dyskinesias. He exhibits no evidence for cognitive impairment, although has noted depression. Haplotype analysis revealed all 11 PARK2 microsatellite markers were homozygous, spanning a genetic distance >22.4 cM"	pedigree
PINK1	1p36.12	Exon 6-8	deletion	Homozygous	Patient A1	15955953	"Sequencing,PCR,FISH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 6-8	deletion	Homozygous	Patient B2	15955953	"Sequencing,PCR,FISH"	Japan	Japanese	F	39	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 6-8	deletion	Homozygous	Patient B3	15955953	"Sequencing,PCR,FISH"	Japan	Japanese	M	44	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 7 	deletion	Heterozygous	IV. 11	16130111	Sanger	Italy	European	F	55	N	U	d levodopa-responsive parkinsonism	Life Span:1909-1980Age of Onset:55Disease Duration:16First Symptom:Tremorupper limb resting tremor:+lower limb resting tremor:+akinesia:+rigidity:+postural instability:+Response to Dopaminergic Therapy:LdSide Effects to Dopaminergic Therapy:UNKH-Y:VUPDRS Off:	pedigree
PRKN	6q26	Exon 7 	deletion	Heterozygous	IV. 17	16130111	Sanger	Italy	European	M	76	N	U	d levodopa-responsive parkinsonism	Life Span:1919-1993Age of Onset:45Disease Duration:29 First Symptom:Akinesiaupper limb resting tremor:lower limb resting tremor:akinesia:+rigidity:+postural instability:+Response to Dopaminergic Therapy:LdSide Effects to Dopaminergic Therapy:UNKH-Y:IVUPDRS Off:	pedigree
PRKN	6q26	Exon 7 	deletion	Heterozygous	IV. 31	16130111	Sanger	Italy	European	M	64	N	U	d levodopa-responsive parkinsonism	Life Span:1927-Age of Onset:64Disease Duration:9First Symptom:Tremorupper limb resting tremor:+lower limb resting tremor:+akinesia:+rigidity:+postural instability:+Response to Dopaminergic Therapy:LdSide Effects to Dopaminergic Therapy:-H-Y:IIIUPDRS Off:54	pedigree
PRKN	6q26	Exon 7 	deletion	Heterozygous	IV. 33	16130111	Sanger	Italy	European	M	49	N	U	d levodopa-responsive parkinsonism	"Life Span:1930-2004Age of Onset:49Disease Duration:21First Symptom:Tremor upper limb resting tremor:+lower limb resting tremor:akinesia:+rigidity:+postural instability:+Response to Dopaminergic Therapy:Ld+DASide Effects to Dopaminergic Therapy:MF,DysH-Y:IVUPDRS Off:68"	pedigree
PRKN	6q26	Exon 7 	deletion	Heterozygous	IV. 37	16130111	Sanger	Italy	European	M	48	N	U	d levodopa-responsive parkinsonism	Life Span:1933-1998Age of Onset:48Disease Duration:16First Symptom:Tremorupper limb resting tremor:lower limb resting tremor:akinesia:rigidity:postural instability:Response to Dopaminergic Therapy:Ld+DASide Effects to Dopaminergic Therapy:DysH-Y:IIIUPDRS Off: 55	pedigree
PRKN	6q26	Exon 7 	deletion	Heterozygous	IV. 42	16130111	Sanger	Italy	European	M	31	N	U	d levodopa-responsive parkinsonism	Life Span:1935-Age of Onset:31Disease Duration:34First Symptom:Tremorupper limb resting tremor:+lower limb resting tremor:+akinesia:+rigidity:+postural instability:+Response to Dopaminergic Therapy:Ld+DASide Effects to Dopaminergic Therapy:DysH-Y:IIIUPDRS Off: 49	pedigree
PRKN	6q26	Exon 7 	deletion	Heterozygous	V. 2	16130111	Sanger	Italy	European	M	72	N	U	d levodopa-responsive parkinsonism	Life Span:1926-Age of Onset:72Disease Duration:2First Symptom:Akinesiaupper limb resting tremor:lower limb resting tremor:akinesia:+rigidity:+postural instability:Response to Dopaminergic Therapy:Ld Side Effects to Dopaminergic Therapy:-H-Y:IIUPDRS Off:28	pedigree
PRKN	6q26	Exon 7 	deletion	Heterozygous	V. 3	16130111	Sanger	Italy	European	F	20	N	U	d levodopa-responsive parkinsonism	Life Span:1933-Age of Onset:20Disease Duration:47First Symptom:Tremorupper limb resting tremor:+lower limb resting tremor:+akinesia:+rigidity:+postural instability:Response to Dopaminergic Therapy:LdSide Effects to Dopaminergic Therapy:-H-Y:IIUPDRS Off:25  	pedigree
SNCA	4q22.1	Exon 1-2	duplication	U	A-13	16358335	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	48	N	U	U	U	pedigree
SNCA	4q22.1	Exon 1-2	duplication	U	A-15	16358335	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	38	N	U	U	U	pedigree
SNCA	4q22.1	Exon 1-2	duplication	U	B-1	16358335	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	47	N	U	U	U	pedigree
PRKN	6q26	Exon 5_6	deletion	Heterozygous	II:2	16476817	RFLP	USA	American	M	36	N	U	early-onset Parkinson disease	Tremor:+Rigidity:+Bradykinesia:+Upper motor neuron signs:AbsentCognitive status:MMSE 27/30Response therapy:LevodopaFluctuations:Yes 	pedigree
PRKN	6q26	Exon 5_6	deletion	Heterozygous	II:7	16476817	RFLP	USA	American	F	38	N	U	early-onset Parkinson disease	Tremor:+Rigidity:+Bradykinesia:+Upper motor neuron signs:AbsentCognitive status:NEResponse therapy:LevodopaFluctuations:No 	pedigree
PRKN	6q26	Exon 5_6	deletion	Heterozygous	II:11	16476817	RFLP	USA	American	M	34	N	U	early-onset Parkinson disease	Tremor:+Rigidity:+Bradykinesia:+Upper motor neuron signs:AbsentCognitive status:NormalResponse therapy:Agonists onlyFluctuations:No	pedigree
PRKN	6q26	Exon 5_6	deletion	Heterozygous	II:12	16476817	RFLP	USA	American	F	30	N	U	early-onset Parkinson disease	Tremor:+Rigidity:+Bradykinesia:+Upper motor neuron signs:AbsentCognitive status:NEResponse therapy:LevodopaFluctuations:No 	pedigree
PRKN	6q26	Exon3-4 	deletion	Heterozygous	PR488 	16793319	PCR/SSCP/Sanger	India	Indian	F	31	N	U	typical PD	Parkinson's disease	pedigree/sporadic
PRKN	6q26	Exon3-4 	deletion	Heterozygous	PR546	16793319	PCR/SSCP/Sanger	India	Indian	F	31	N	U	typical PD	Parkinson's disease	pedigree/sporadic
PINK1	1p36.12	g.15445_15467	deletion	heterozygous	17154281-1	17154281	ABI PRISM 3100 automated DNA sequencer	Italy	Europe	F	46	N	U	LOPD	U	sporadic
PINK1	1p36.12	Exon 7	deletion	Heterozygous	III:1	17154281	"qPCR, FISH, Microsat- ellite markers analysis"	Italy	Italian	F	38	N	U	EOPD	U	sporadic
SNCA	4q22.1	Exon 2-3	duplication	U	Branch J	17251522	qPCR; Microsatellite markers analysis; Affymetrix 250K microarray	Sweden	Sweden	F	71	N	U	LOPD	U	pedigree
SNCA	4q22.1	Exon 2-3	triplication	U	Branch I	17251522	qPCR; Microsatellite markers analysis; Affymetrix 253K microarray	United States	Sweden	M	31	N	U	EOPD	U	pedigree
PRKN	6q26	Exon3-6	deletion	Heterozygous	III:3	17353387	Semi-quantitative PCR	USA	Mexican	F	36	N	U	EOPD	Presenting symptom Left tremor UPDRS part I mentation score 0Levodopa response  YesDrug-induced dyskinesia  2UPDRS part II ADL score 4UPDRS part III motor score  39Hoehn and Yahr stage 1.5 UPDRS part IV complications score 1 	pedigree
PRKN	6q26	Exon3-6	deletion	Heterozygous	III:6	17353387	Semi-quantitative PCR	USA	Mexican	F	27	N	U	EOPD	Presenting symptom Right leg tremorUPDRS part I mentation score 0Levodopa response  YesDrug-induced dyskinesia  0UPDRS part II ADL score 0UPDRS part III motor score 22Hoehn and Yahr stage 2.5 UPDRS part IV complications score 0	pedigree
SNCA	4q22.1	Exon 3	duplication	U	A-3	17625105	"Semi-quantitative multiplex PCR, FISH"	Korea	Korea	M	40	N	U	EOPD	U	pedigree
SNCA	4q22.1	Exon 3	duplication	U	B-1	17625105	"Semi-quantitative multiplex PCR, FISH"	Korea	Korea	F	65	N	U	LOPD	U	sporadic
SNCA	4q22.1	Exon 3	duplication	U	C-2	17625105	"Semi-quantitative multiplex PCR, FISH"	Korea	Korea	M	50	N	U	U	U	sporadic
PRKN	6q26	Exon 5	deletion	Homozygous	V1	17676595	"SNPArrays,array-based Comparative Genomic Hybridization"	Eastern Turkey	Eastern Turkey	F	U	N	U	U	U	pedigree
PRKN	6q26	Exon 6	deletion	Homozygous	V2	17676595	"SNPArrays,array-based Comparative Genomic Hybridization"	Eastern Turkey	Eastern Turkey	F	U	N	U	U	U	pedigree
PRKN	6q26	Exon 7	deletion	Homozygous	V3	17676595	"SNPArrays,array-based Comparative Genomic Hybridization"	Eastern Turkey	Eastern Turkey	F	U	N	U	U	U	pedigree
PRKN	6q26	Exon 8	deletion	Homozygous	V8	17676595	"SNPArrays,array-based Comparative Genomic Hybridization"	Eastern Turkey	Eastern Turkey	F	U	N	U	U	U	pedigree
PRKN	6q26	Exon 9	deletion	Homozygous	V9	17676595	"SNPArrays,array-based Comparative Genomic Hybridization"	Eastern Turkey	Eastern Turkey	F	U	N	U	U	U	pedigree
PRKN	6q26	Exon 10	deletion	Homozygous	V7	17676595	"SNPArrays,array-based Comparative Genomic Hybridization"	Eastern Turkey	Eastern Turkey	M	U	N	U	U	U	pedigree
PRKN	6q26	Exon3	deletion	heterozygous	II:8	18068301	sanger	America	Caucasian	M	38	N	U	EOPD	"slow progression,beneficial response to levodopa, and levodopa-related motor complications."	pedigree
PRKN	6q26	Exon 3_4	deletion	heterozygous	II:3	18068301	sanger	America	Caucasian	F	39	N	U	EOPD	"slow progression,beneficial response to levodopa, and levodopa-related motor complications."	pedigree
SNCA	4q22.1	Exon 2-6	duplication	Heterozygous	II-4	18413475	"Microsatellite markers analysis, qPCR"	Japan	Japan	M	71	N	U	LOPD	U	pedigree
SNCA	4q22.1	Exon 2-6	duplication	Heterozygous	III-1	18413475	"Microsatellite markers analysis, qPCR"	Japan	Japan	F	61	N	U	LOPD	U	pedigree
SNCA	4q22.1	Exon 2-6	duplication	Heterozygous	IV-1	18413475	"Microsatellite markers analysis, qPCR"	Japan	Japan	M	39	N	U	EOPD	U	pedigree
SNCA	4q22.1	Exon 2-6	duplication	Homozygous	IV-2	18413475	"Microsatellite markers analysis, qPCR"	Japan	Japan	M	28	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	triplication	U	18571778-1	18571778	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 262 K microarray"	Iowan	Iowan	U	U	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	triplication	U	18571778-2	18571778	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 263 K microarray"	US	US	U	U	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	18571778-3	18571778	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 264 K microarray"	Swedish	Swedish	U	U	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	18571778-4	18571778	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 265 K microarray"	French	French	U	U	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	18571778-5	18571778	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 266 K microarray"	Japan	Japanese	U	U	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	18571778-6	18571778	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 267 K microarray"	Japan	Japanese	U	U	N	U	U	U	pedigree
PRKN	6q26	Exon4	deletion	Homozygous	18704525-1	18704525	MLPA	Korea	Asian	U	13	U	U	EOPD	U	sporadic
PRKN	6q26	"Exon 2, Exon 4"	deletion	Compound heterozygous	18704525-2	18704525	MLPA	Korea	Asian	U	24	U	U	EOPD	U	sporadic
PRKN	6q26	Exon4	deletion	Heterozygous	18704525-3	18704525	MLPA	Korea	Asian	F	37	U	U	EOPD	U	sporadic
PRKN	6q26	 Exon4	deletion	Homozygous	18704525-1	18704525	MLPA+sanger	Korea	Asian	U	U	U	U	EOPD	U	sporadic
PRKN	6q26	 Exon4	deletion	Heterozygous	18704525-3	18704525	MLPA+sanger	Korea	Asian	U	U	U	U	EOPD	U	sporadic
PRKN	6q26	"Exon2, Exon4"	deletion	Heterozygous	18704525-2	18704525	MLPA+sanger	Korea	Asian	U	U	U	U	EOPD	U	sporadic
PRKN	6q26	"Exon 3, Exon12"	deletion	heterozygous	family1:II-1	18785233	sanger	China	Chinese	U	19	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(1),Diurnal-fluctuations(1),Foot-dystonia(1),Response-to-levodopa(Good),Dyskinesia(1),"	pedigree
PRKN	6q26	"Exon 3, Exon12"	deletion	Homozygous	family1:II-2	18785233	sanger	China	Chinese	U	19	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(1),Diurnal-fluctuations(1),Foot-dystonia(1),Response-to-levodopa(Good),Dyskinesia(1),"	pedigree
PRKN	6q26	Exon 4	deletion	heterozygous	family2:II-1	18785233	sanger	China	Chinese	U	14	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(1),Diurnal-fluctuations(1),Foot-dystonia(1),Response-to-levodopa(Good),Dyskinesia(1),"	pedigree
PRKN	6q26	Exon 3-4	deletion	heterozygous	family8:II-5	18785233	sanger	China	Chinese	U	24	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(1),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 2-4	deletion	heterozygous	family3:II-3	18785233	sanger	China	Chinese	U	28	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 2-4	deletion	heterozygous	family3:II-4	18785233	sanger	China	Chinese	U	24	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	"Exon 3, Exon7"	deletion	heterozygous	family19:II-4	18785233	sanger	China	Chinese	U	24	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 2-4	deletion	heterozygous	family28:II-3	18785233	sanger	China	Chinese	U	26	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 4	deletion	Homozygous	family13:II-1	18785233	sanger	China	Chinese	U	37	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 4	deletion	Homozygous	family13:II-2	18785233	sanger	China	Chinese	U	29	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 2	deletion	Homozygous	family25:IV-2	18785233	sanger	China	Chinese	U	19	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 4	deletion	heterozygous	family26:II-2	18785233	sanger	China	Chinese	U	38	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(No-use),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 4	deletion	heterozygous	family26:II-3	18785233	sanger	China	Chinese	U	33	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(No-use),Dyskinesia(2),"	pedigree
PRKN	6q26	"Exon 2, Exon9"	deletion	heterozygous	family15:II-2	18785233	sanger	China	Chinese	U	31	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(1),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 7	deletion	Homozygous	family25:II-1	18785233	sanger	China	Chinese	U	13	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(1),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 4	deletion	heterozygous	family26:II-7	18785233	sanger	China	Chinese	U	33	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 3-4	deletion	heterozygous	family29:II-2	18785233	sanger	China	Chinese	U	24	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(2),Postural-tremor(2),Hyperreflexia(1),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(1),"	pedigree
PRKN	6q26	Exon 3-4	deletion	Homozygous	family16:II-1	18785233	sanger	China	Chinese	U	16	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(1),Resting-tremor(2),Postural-tremor(2),Hyperreflexia(2),Diurnal-fluctuations(1),Foot-dystonia(1),Response-to-levodopa(Good),Dyskinesia(1),"	pedigree
PRKN	6q26	Exon 4	deletion	heterozygous	family6:II-2	18785233	sanger	China	Chinese	U	23	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(2),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(1),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 2	deletion	Homozygous	family25:IV-3	18785233	sanger	China	Chinese	U	18	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(2),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(No-use),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 3-4	deletion	heterozygous	family29:II-1	18785233	sanger	China	Chinese	U	27	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(2),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(1),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(1),"	pedigree
PRKN	6q26	Exon 3-4	deletion	heterozygous	family29:II-3	18785233	sanger	China	Chinese	U	31	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(2),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(2),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(1),"	pedigree
PRKN	6q26	Exon 3-4	deletion	heterozygous	family29:II-4	18785233	sanger	China	Chinese	U	30	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(2),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(2),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(1),"	pedigree
PRKN	6q26	Exon 2	deletion	heterozygous	family9:II-2	18785233	sanger	China	Chinese	U	42	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(2),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(1),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 2	deletion	heterozygous	family9:II-1	18785233	sanger	China	Chinese	U	40	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(2),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 1	deletion	heterozygous	family29:II-1	18785233	sanger	China	Chinese	U	31	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(2),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 3-4	deletion	heterozygous	family8:II-2	18785233	sanger	China	Chinese	U	29	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(2),Resting-tremor(2),Postural-tremor(2),Hyperreflexia(1),Diurnal-fluctuations(1),Foot-dystonia(1),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	Exon 3	deletion	Homozygous	family17:II-3	18785233	sanger	China	Chinese	U	28	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(1),Postural-instability(2),Resting-tremor(2),Postural-tremor(2),Hyperreflexia(2),Diurnal-fluctuations(1),Foot-dystonia(1),Response-to-levodopa(Good),Dyskinesia(1),"	pedigree
PRKN	6q26	Exon 4	deletion	Homozygous	family18:II-5	18785233	sanger	China	Chinese	U	24	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(2),Postural-instability(2),Resting-tremor(1),Postural-tremor(1),Hyperreflexia(2),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	"Exon 3, Exon7"	deletion	heterozygous	family19:II-2	18785233	sanger	China	Chinese	U	23	N	U	EOPD 	"Rigidity(1),Bradykinesia(1),Shuffling-gait(2),Postural-instability(2),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(2),Diurnal-fluctuations(1),Foot-dystonia(2),Response-to-levodopa(Good),Dyskinesia(2),"	pedigree
PRKN	6q26	"Exon 2, Exon9"	deletion	heterozygous	family15:II-3	18785233	sanger	China	Chinese	U	31	N	U	EOPD 	"Rigidity(1),Bradykinesia(2),Shuffling-gait(2),Postural-instability(2),Resting-tremor(1),Postural-tremor(2),Hyperreflexia(1),Diurnal-fluctuations(2),Foot-dystonia(2),Response-to-levodopa(No-use),Dyskinesia(2),"	pedigree
SNCA	4q22.1	Exon 2	duplication	U	Patient 1	18852445	qPCR	Japan	Japan	M	47	N	U	EOPD	U	pedigree
SNCA	4q22.1	Exon 2	duplication	U	Patient 2	18852445	qPCR	Japan	Japan	F	68	N	U	LOPD	U	pedigree
SNCA	4q22.1	Exon 3	duplication	U	18852448-1	18852448	"qPCR, MLPA"	Germany	Germany	F	36	N	U	EOPD	U	sporadic
SNCA	4q22.1	Exon 3	duplication	U	18852449-1	18852449	"MLPA, Microsatellite markers analysis"	U	European	F	35	N	U	EOPD	U	sporadic
PARK7	1p36.23	Exon 7	duplication	Heterozygous	case 12	18973254	"MLPA,Sequencing"	Dutch	Dutch	M	33	N	U	EOPD	U	sporadic
PARK7	1p36.23	Exon 7	duplication	Heterozygous	case 13	18973254	"MLPA,Sequencing"	Dutch	Dutch	M	47	N	U	EOPD	U	pedigree
PARK7	1p36.23	Exon 7	duplication	Heterozygous	case 14	18973254	"MLPA,Sequencing"	Dutch	Dutch	F	46	N	U	EOPD	U	pedigree
PRKN	6q26	Exon4	deletion	Homozygous	19087301-2	19087301	MLPA	Jordan	U	M	32	U	U	U	U	pedigree
PRKN	6q26	Exon4	deletion	Homozygous	19087301-3	19087301	MLPA	Jordan	U	M	32	U	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	triplication	U	FPD-014	19139307	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 257 K microarray"	Italy	Italian	M	48	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	duplication	U	FPD-131	19139307	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 258 K microarray"	Italy	Italian	M	48	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	duplication	U	FPD-321	19139307	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 259 K microarray"	Italy	Italian	F	46	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	duplication	U	FPD-410	19139307	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 260 K microarray"	Italy	Italian	F	50	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 3, 4"	duplication	U	FPD-437	19139307	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 261 K microarray"	Italy	Italian	F	38	N	U	U	U	pedigree
PINK1	1p36.12	Exon 7	deletion	Homozygous	2035-112	19205068	"Sequencing,qPCR"	Brazil	Brazil	F	24	N	U	EOPD	U	sporadic
COMT	22q11.2	COMT	deletion	Heterozygous	Patient 1	19208384	FISH	U	U	M	42	N	U	EOPD	U	sporadic
COMT	22q11.2	COMT	deletion	Heterozygous	Patient 2	19208384	FISH	U	U	M	43	N	U	EOPD	U	sporadic
PINK1	1p36.12	Exon 4-8	deletion	Homozygous	Patient no. 1	19214605	"MLPA,sequencing"	Sudan	Sudan	M	15	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 4-8	deletion	Homozygous	Patient no. 2	19214605	"MLPA,sequencing"	Sudan	Sudan	F	21	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 4-8	deletion	Homozygous	Patient no. 3	19214605	"MLPA,sequencing"	Sudan	Sudan	M	11	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 2-12	duplication	Heterozygous	DR132.1	19405094	semiquantitative multiplex polymerase chain reaction (PCR)	Belgian	Belgian	M	64	N	U	U	U	sporadic
PRKN	6q26	Exon 2	duplication	Heterozygous	DR293.1	19405094	semiquantitative multiplex polymerase chain reaction (PCR)	Belgian	Belgian	M	39	N	U	U	U	sporadic
PRKN	6q26	Exon 2	duplication	Heterozygous	DR284.1	19405094	semiquantitative multiplex polymerase chain reaction (PCR)	Belgian	Belgian	M	43	N	U	U	U	sporadic
PRKN	6q26	Exon 2-3	duplication	Heterozygous	DR295.1	19405094	semiquantitative multiplex polymerase chain reaction (PCR)	Belgian	Belgian	F	57	N	U	U	U	sporadic
PRKN	6q26	Exon 3	duplication	Heterozygous	DR263.1	19405094	semiquantitative multiplex polymerase chain reaction (PCR)	Belgian	Belgian	F	50	N	U	U	U	sporadic
PRKN	6q26	Exon 3-4	duplication	Heterozygous	DR296.1	19405094	semiquantitative multiplex polymerase chain reaction (PCR)	Belgian	Belgian	F	42	N	U	U	U	sporadic
PRKN	6q26	Exon 3-6	deletion	Heterozygous	DR382.1	19405094	semiquantitative multiplex polymerase chain reaction (PCR)	Belgian	Belgian	M	42	N	U	U	U	sporadic
PRKN	6q26	Exon 6	duplication	Heterozygous	DR297.1	19405094	semiquantitative multiplex polymerase chain reaction (PCR)	Belgian	Belgian	F	67	N	U	U	U	sporadic
SNCA	4q22.1	Exon 2	duplication	Heterozygous	DR292.1	19405094	semiquantitative multiplex polymerase chain reaction (PCR)	Belgian	Belgian	U	U	N	U	U	U	sporadic
SNCA	4q22.1	SNCA	duplication	U	A-II-9	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	48	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	A-II-11	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	38	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	B-II-7	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	47	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	C-III-3	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	49	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	D-III-1	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	56	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	D-III-5	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	38	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	E-III-4	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	54	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	E-III-6	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	53	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	F-II-5	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	62	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	F-III-2	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	37	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	G-III-1	19562770	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	31	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	II-1	19833540	"MLPA, Agilent 105A chip"	Italy	Italian	F	41	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	I-2	19833540	"MLPA, Agilent 105A chip"	Italy	Italian	F	47	N	U	EOPD	U	pedigree
SNCA	4q22.1	"Exon 1,3-6"	duplication	U	20013014-1	20013014	"qPCR, MLPA"	French	Caucasian	U	46	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 4	deletion	Heterozygous	Patient 17	20146068	qPCR	China	chinese	F	40	N	U	EOPD	U	sporadic
PINK1	1p36.12	Exon 7	deletion	Heterozygous	Patient 18	20146068	qPCR	China	chinese	M	40	N	U	EOPD	U	sporadic
PINK1	1p36.12	Exon 7	deletion	Heterozygous	Patient 19	20146068	qPCR	China	chinese	M	47	N	U	EOPD	U	sporadic
PINK1	1p36.12	Exon 3-8	deletion	Heterozygous	Patient 20	20146068	qPCR	China	chinese	F	44	N	U	EOPD	U	sporadic
PARK7	1p36.23	Exon 2	deletion	Heterozygous	Patient 21	20146068	qPCR	China	chinese	F	46	N	U	EOPD	U	sporadic
PARK7	1p36.23	Exon 2	deletion	Heterozygous	Patient 22	20146068	qPCR	China	chinese	M	34	N	U	EOPD	U	sporadic
PARK7	1p36.23	Exon 2	deletion	Heterozygous	Patient 23	20146068	qPCR	China	chinese	M	32	N	U	EOPD	U	sporadic
SNCA	4q22.1	Exon 4	duplication	U	Patient 1	20222138	Semi-quantitative Multiplex PCR	Korea	Korea	F	48	N	U	U	U	sporadic
SNCA	4q22.1	Exon 4	duplication	U	Patient 2	20222138	Semi-quantitative Multiplex PCR	Korea	Korea	F	55	N	U	U	U	sporadic
PINK1	1p36.12	Exon 7	deletion	Heterozygous	Individual III:2	20356854	"Sequencing,qPCR"	Spain	Spanish	F	34	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 7	deletion	Heterozygous	Individual III:3	20356854	"Sequencing,qPCR"	Spain	Spanish	F	45	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 7	deletion	Heterozygous	Individual IV:3	20356854	"Sequencing,qPCR"	Spain	Spanish	F	31	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 7	deletion	Heterozygous	Individual IV:5	20356854	"Sequencing,qPCR"	Spain	Spanish	M	38	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 7	deletion	Heterozygous	Individual IV:9	20356854	"Sequencing,qPCR"	Spain	Spanish	M	31	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 7	deletion	Heterozygous	Individual IV:11	20356854	"Sequencing,qPCR"	Spain	Spanish	M	27	N	U	EOPD	U	pedigree
PINK1	1p36.12	Exon 7	deletion	Heterozygous	Individual V:2	20356854	"Sequencing,qPCR"	Spain	Spanish	M	14	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 2	deletion	Heterozygous	20558392-1	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2	duplication	Heterozygous	20558392-2	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3	deletion	Heterozygous	20558392-3	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3-4	deletion	Heterozygous	20558392-4	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3-4	deletion	Heterozygous	20558392-5	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 5-6	deletion	Heterozygous	20558392-6	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 6	deletion	Heterozygous	20558392-7	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 6	deletion	Heterozygous	20558392-8	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Hispanic	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 8	deletion	Heterozygous	20558392-9	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Hispanic	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 10	deletion	Heterozygous	20558392-10	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3-4	deletion	Homozygous	20558392-11	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Hispanic	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3-4	deletion	Homozygous	20558392-12	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Hispanic	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 6	deletion	Compound heterozygote	20558392-13	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	"Exon 3,5"	deletion	Compound heterozygote	20558392-14	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	"Exon 3,12"	deletion	Compound heterozygote	20558392-15	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3-4	deletion	Compound heterozygote	20558392-16	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 4	deletion	Compound heterozygote	20558392-17	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 4	deletion	Compound heterozygote	20558392-18	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
PRKN	6q26	"Exon 7,8,10"	deletion	Compound heterozygote	20558392-19	20558392	semiquantitative multiplex polymerase chain reaction (PCR)	U	Caucasian 	U	U	N	U	EOPD	U	sporadic
TH	11p15.4	TH	deletion	heterozygous	20809526-1	20809526	SNP arrays	America	U	U	54	N	U	U	"no evidence for dystonia,presented clinically with difficulty in the dexterity of the right hand and a typical asymmetric presentation. The patien's symptoms were responsive to L-DOPA.Examination at the time of ascertainment revealed a Hoehn-Yahr rating of 2, Schwab and England level of 90%,and UPDRS part III motor score of 23 when tested in an on state. There was no evidence of dystonia by exam orby history."	sporadic
SNCA	4q22.1	"Exon 1, 7"	triplication	U	II-1	20818659	"qPCR, MLPA, microsatellite analysis"	Japan	Japanese	M	49	N	U	EOPD	U	pedigree
SNCA	4q22.1	"Exon 1, 7"	triplication	U	III-1	20818659	"qPCR, MLPA, microsatellite analysis"	Japan	Japanese	M	33	N	U	EOPD	U	pedigree
SNCA	4q22.1	"Exon 1, 7"	triplication	U	IV-1	20818659	"qPCR, MLPA, microsatellite analysis"	Japan	Japanese	M	28	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 2-9	deletion	Heterozygous	20876472-1	20876472	semi quantitative PCR and multiplex ligation-dependent probe amplification	U	U	U	U	N	U	U	U	sporadic
PRKN	6q26	Exon 2-9	duplication	Heterozygous	20876472-2	20876472	semi quantitative PCR and multiplex ligation-dependent probe amplification	U	U	U	U	N	U	U	U	sporadic
PRKN	6q26	Exon4 	deletion	heterozygous	S3072	21322020	sanger and a semi-quantitative PCR		Iranian	M	33	N	U	EOPD	"Duration 33years,Tremor, Bradykinesia, Postural Instability, Response to levadopa, Handwriting."	sporadic
PRKN	6q26	Exon3	deletion	homozygous	R1030	21322020	sanger and a semi-quantitative PCR		Iranian	M	28	N	U	EOPD	"Duration 33years,Tremor, Bradykinesia, Postural Instability, Response to levadopa, Voice change, consanguineous parents."	sporadic
PRKN	6q26	Exon5-6	deletion	homozygous	S3040	21322020	sanger and a semi-quantitative PCR		Iranian	M	30	N	U	EOPD	"Duration 33years,Tremor, Bradykinesia, Rigidity, Postural Instability, Response to levadopa, Voice change, Positive sleep response, consanguineous parents."	sporadic
PRKN	6q26	Exon5	deletion	homozygous	S3052	21322020	sanger and a semi-quantitative PCR		Iranian	M	20	N	U	EOPD	"Duration 43years,Tremor, Bradykinesia, Rigidity, Response to levadopa, Handwriting, Positive sleep response."	sporadic
PRKN	6q26	Exon10dup	duplication	heterozygous	T2016	21322020	sanger and a semi-quantitative PCR		Iranian	M	41	N	U	EOPD	"Duration 10years, Bradykinesia, Rigidity, Postural Instability, Response to levadopa, Voice change, Handwriting, Positive sleep response, consanguineous parents."	sporadic
SNCA	4q22.1	"Exon 1, 7"	duplication	Heterozygous	II2	21412942	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 260 K microarray"	Iowan	Iowan	F	U	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 1, 7"	duplication	Heterozygous	III1	21412942	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 261 K microarray"	Iowan	Iowan	M	U	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 1, 7"	duplication	Heterozygous	III2	21412942	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 262 K microarray"	Iowan	Iowan	F	U	N	U	U	U	pedigree
SNCA	4q22.1	"Exon 1, 7"	duplication	Heterozygous	III4	21412942	"Semi-quantitative Multiplex PCR, Microsatellite analysis, Affymetrix GeneChip Human Mapping 263 K microarray"	Iowan	Iowan	F	U	N	U	U	U	pedigree
PINK1	1p36.12	Exon 1	deletion	Heterozygous	2083	22377733	WES	Brazil	Brazilian	M	45	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 4	deletion	Heterozygous	2096	22377733	WES	Brazil	Brazilian	M	12	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 4	duplication	Heterozygous	2256	22377733	WES	Brazil	Brazilian	F	37	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 5-6	deletion	Heterozygous	2396	22377733	WES	Brazil	Brazilian	M	46	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 3	duplication	Heterozygous	2396	22377733	WES	Brazil	Brazilian	M	46	N	U	EOPD	U	pedigree
SNCA	4q22.1	"Exon 1, 3-6"	duplication	Heterozygous	22410449-1	22410449	"Karyotype, aCGH, MLPA"	Belgium	Belgium	F	21	N	U	EOPD	U	sporadic
SNCA	4q22.1	SNCA	duplication	U	III-2	23124679	"gene-sequencing techniques,qPCR"	Japan	Japanese	M	20	N	U	EOPD	"had experienced tremors in his right hand since his twenties. The tremor then appeared in his left hand a few years later. At the age of 33, he first visited our hospital, complaining of a stagger after running and difficulty in handling the mouse of a personal computer."	pedigree
SNCA	4q22.1	"Exon 1, 3-6"	duplication	Homozygous	IV-3	23283657	"MLPA, Nimblegen 135 K-array CGH"	Pakistan	Pakistan	F	31	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 3	duplication	Heterozygous	Fam1_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	37	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 2	duplication	Heterozygous	Fam7_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	65	N	U	LOPD	U	pedigree
PRKN	6q26	Exon 2	duplication	Heterozygous	Fam9_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	53	N	U	LOPD	U	pedigree
PRKN	6q26	Exon 2	duplication	Heterozygous	Fam10_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	44	N	U	LOPD	U	sporadic
PRKN	6q26	Exon 3	deletion	Heterozygous	Fam4_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	38	N	U	EOPD	U	pedigree
PRKN	6q26	"Exon 2,7-9"	deletion	Heterozygous	Fam6_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	26	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 3-4	deletion	Heterozygous	Fam13_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	59	N	U	LOPD	U	pedigree
PRKN	6q26	Exon 2	deletion	Heterozygous	Fam2_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	19	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 2	deletion	Heterozygous	Fam8_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	60	N	U	LOPD	U	pedigree
PRKN	6q26	Exon 4-6	deletion	Heterozygous	Fam18_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	28	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 5	deletion	Heterozygous	Fam19_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	52	N	U	LOPD	U	pedigree
PRKN	6q26	Exon 4	deletion	Homozygous	Fam14_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	14	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 6	deletion	Homozygous	Fam15_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	27	N	U	EOPD	U	pedigree
PRKN	6q26	"Exon 2-4,6"	deletion	Heterozygous	Fam12_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	25	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 2	deletion	Heterozygous	Fam17_1	23616242	semiquantitative multiplex polymerase chain reaction (PCR)	USA	U	U	16	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	Heterozygous	Patient A-II:1	23744550	"MLPA, qPCR, Affym- etrix high-resolution single nucleotide polymorphism- array analysis"	Argentina	Northern Argentina	M	43	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	Heterozygous	Patient A-II:2	23744550	"MLPA, qPCR, Affym- etrix high-resolution single nucleotide polymorphism- array analysis"	Argentina	Northern Argentina	F	44	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	Heterozygous	Patient B-III:2	23744550	"MLPA, qPCR, Affym- etrix high-resolution single nucleotide polymorphism- array analysis"	Italy	Italian	M	32	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	Heterozygous	Patient B-II:2	23744550	"MLPA, qPCR, Affym- etrix high-resolution single nucleotide polymorphism- array analysis"	Italy	Italian	F	78	N	U	LOPD	U	pedigree
PRKN	6q26	Exon2	deletion	heterozygous	24313877-21	24313877	MLPA	Greece	European	M	41	U	U	U	Tremor	pedigree
PRKN	6q26	Exon2-3	duplication	heterozygous	24313877-22	24313877	MLPA	Greece	European	F	82	U	U	U	"Tremor,late dementia"	pedigree
SNCA	4q22.1	SNCA	duplication	U	Patient 1	24552873	"MLPA,FISH"	American	American	M	32	N	U	EOPD	U	sporadic
SNCA	4q22.1	SNCA	duplication	U	Patient 2	24552873	"MLPA,FISH"	U	European	M	18	N	U	EOPD	U	sporadic
PINK1	1p36.12	Exon1	deletion	Homozygous	24677602-26	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	24	U	U	EOPD	"Asymmetric presentation of PD,Rigidity, Anxiety, Motor "	pedigree
PINK1	1p36.12	Exon1	deletion	Homozygous	24677602-27	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	40	U	U	EOPD	"Asymmetric presentation of PD, RBD, insomnia"	sporadic
PINK1	1p36.12	"Exon2, Exon4-5"	deletion	Homozygous	24677602-28	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	34	U	U	EOPD	"Asymmetric presentation of PD,Freezing "	sporadic
PINK1	1p36.12	Exon1	deletion	heterozygous	24677602-29	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	44	U	U	EOPD	"Asymmetric presentation of PD,Rigidity, RBD "	sporadic
PRKN	6q26	Exon9	deletion	Homozygous	24677602-1	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	44	U	U	EOPD	Asymmetric presentation of PD	sporadic
PRKN	6q26	Exon10	deletion	Homozygous	24677602-2	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	37	U	U	EOPD	U	sporadic
PRKN	6q26	Exon12	deletion	Homozygous	24677602-3	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	38	U	U	EOPD	"Asymmetric presentation of PD,Dementia, dysphagia,ocular movements limitation, RBD;Dyskinesia, poor levodopa response"	pedigree
PRKN	6q26	"Exon1-4, Exon6-12"	deletion	compound heterozygous	24677602-4	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	37	U	U	EOPD	"Asymmetric presentation of PD,Dyskinesia"	sporadic
PRKN	6q26	"Exon3-4, Exon9-10"	deletion	compound heterozygous	24677602-5	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	43	U	U	EOPD	"Asymmetric presentation of PD,Dyskinesia"	sporadic
PRKN	6q26	"Exon3-4, Exon9-12"	deletion	compound heterozygous	24677602-6	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	28	U	U	EOPD	"Asymmetric presentation of PD,Depression, constipation, cognitive decline"	sporadic
PRKN	6q26	"Exon4, Exon9"	deletion	compound heterozygous	24677602-7	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	36	U	U	EOPD	"Asymmetric presentation of PD,Dementia, dysphagia,ocular movements limitation, RBD;Dyskinesia, poor levodopa response"	sporadic
PRKN	6q26	"Exon6-7, Exon9-10"	deletion	compound heterozygous	24677602-8	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	36	U	U	EOPD	"Asymmetric presentation of PD,Obsessive compulsive disorder,Dyskinesia"	pedigree
PRKN	6q26	"Exon7, Exon10-12"	deletion	compound heterozygous	24677602-9	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	27	U	U	EOPD	"Asymmetric presentation of PD,Depression, striatal hand and foot, anxiety,cognitive decline,Poor levodopa response"	sporadic
PRKN	6q26	Exon9-10	deletion	compound heterozygous	24677602-10	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	41	U	U	EOPD	"Asymmetric presentation of PD, Psychosis, depression,Dyskinesia insomnia"	pedigree
PRKN	6q26	Exon12	duplication	compound heterozygous	24677602-10	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	41	U	U	EOPD	"Asymmetric presentation of PD, Psychosis, depression,Dyskinesia insomnia"	pedigree
PRKN	6q26	Exon2	deletion	heterozygous	24677602-11	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	14	U	U	EOPD	"Asymmetric presentation of PD,Rigidity, Dyskinesia "	pedigree
PRKN	6q26	Exon4	deletion	heterozygous	24677602-13	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	16	U	U	EOPD	"Asymmetric presentation of PD,Cervical dystonia"	sporadic
PRKN	6q26	Exon5	deletion	heterozygous	24677602-14	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	34	U	U	EOPD	"Asymmetric presentation of PD, Anxiety, sleep fragmentation,Delayed-on,  wearing-off.Dyskinesia"	sporadic
PRKN	6q26	Exon6	deletion	heterozygous	24677602-15	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	27	U	U	EOPD	"Asymmetric presentation of PD,Anxiety, depression"	sporadic
PRKN	6q26	Exon7	deletion	heterozygous	24677602-16	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	20	U	U	EOPD	"Asymmetric presentation of PD,Few fluctuations "	pedigree
PRKN	6q26	Exon9	deletion	heterozygous	24677602-17	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	31	U	U	EOPD	"Asymmetric presentation of PD,Depression, insomnia Dyskinesiadepression"	pedigree
PRKN	6q26	Exon9	deletion	heterozygous	24677602-18	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	45	U	U	EOPD	Asymmetric presentation of PD	sporadic
PRKN	6q26	Exon9	deletion	heterozygous	24677602-19	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	42	U	U	EOPD	"Asymmetric presentation of PD,"	pedigree
PRKN	6q26	Exon9	deletion	heterozygous	24677602-20	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	40	U	U	EOPD	"Asymmetric presentation of PD,Pain, constipation, insomnia Dyskinesia"	sporadic
PRKN	6q26	Exon9	deletion	heterozygous	24677602-21	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	36	U	U	EOPD	"Asymmetric presentation of PD,Depression Dystonia, camptocormia, neuropathy"	sporadic
PRKN	6q26	Exon9-10	deletion	heterozygous	24677602-22	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	44	U	U	EOPD	"Asymmetric presentation of PD,Rigidity"	pedigree
PRKN	6q26	Exon10-11	deletion	heterozygous	24677602-23	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	F	33	U	U	EOPD	Tremor	pedigree
PRKN	6q26	Exon12	deletion	heterozygous	24677602-24	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	40	U	U	EOPD	"Asymmetric presentation of PD,"	sporadic
PRKN	6q26	Exon9-12	deletion	heterozygous	24677602-25	24677602	MLPA/RT-PCR	Mexico	Mexican Mestizo patients	M	42	U	U	EOPD	"Asymmetric presentation of PD,Freezing "	sporadic
PRKN	6q26	Exon2	deletion	heterozygous	24729340-4	24729340	MLPA	Mexico	Mexican mestizo	F	28	U 	U	EOPD	"no tremor or men tal impairment were found, but 'poor, response to antiparkinsonian drug therapy was present in this case (LDopa, dopamimetics, anticholinergic and MAO inhibitors). "	sporadic
7SK	4q22.1	7SK	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
7SK	4q22.1	7SK	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
7SK	4q22.1	7SK	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
7SK	4q22.1	7SK	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
7SK	4q22.1	7SK	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
ABCG2	4q22.1	ABCG2	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
ABCG2	4q22.1	ABCG2	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
ABCG2	4q22.1	ABCG2	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
ABCG2	4q22.1	ABCG2	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
ABCG2	4q22.1	ABCG2	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
AK026379	4q22	AK026379	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
AK026379	4q22	AK026379	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
AK026379	4q22	AK026379	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
AK026379	4q22	AK026379	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
AK026379	4q22	AK026379	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
ATOH1	4q22	ATOH1	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
ATOH1	4q22	ATOH1	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
ATOH1	4q22	ATOH1	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
ATOH1	4q22	ATOH1	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
ATOH1	4q22	ATOH1	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
BC027846	4q22.1	BC027846	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
BC027846	4q22.1	BC027846	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
BC027846	4q22.1	BC027846	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
BC027846	4q22.1	BC027846	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
BC027846	4q22.1	BC027846	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
CCSER1	4q22	CCSER1	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
CCSER1	4q22	CCSER1	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
CCSER1	4q22	CCSER1	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
CCSER1	4q22	CCSER1	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
CCSER1	4q22	CCSER1	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
DQ571524	4q22	DQ571524	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
DQ571524	4q22	DQ571524	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
DQ571524	4q22	DQ571524	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
DQ571524	4q22	DQ571524	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
DQ571524	4q22	DQ571524	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
EF565118	4q22	EF565118	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
EF565118	4q22	EF565118	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
EF565118	4q22	EF565118	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
EF565118	4q22	EF565118	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
EF565118	4q22	EF565118	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
FAM13A	4q22.1	FAM13A	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
FAM13A	4q22.1	FAM13A	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
FAM13A	4q22.1	FAM13A	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
FAM13A	4q22.1	FAM13A	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
FAM13A	4q22.1	FAM13A	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
FAM13A-AS1	4q22.1	FAM13A-AS1	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
FAM13A-AS1	4q22.1	FAM13A-AS1	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
FAM13A-AS1	4q22.1	FAM13A-AS1	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
FAM13A-AS1	4q22.1	FAM13A-AS1	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
FAM13A-AS1	4q22.1	FAM13A-AS1	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
GPRIN3	4q22	GPRIN3	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
GPRIN3	4q22	GPRIN3	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
GPRIN3	4q22	GPRIN3	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
GPRIN3	4q22	GPRIN3	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
GPRIN3	4q22	GPRIN3	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
GRID2	4q22	GRID2	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
GRID2	4q22	GRID2	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
GRID2	4q22	GRID2	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
GRID2	4q22	GRID2	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
GRID2	4q22	GRID2	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
HERC3	4q22.1	HERC3	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
HERC3	4q22.1	HERC3	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
HERC3	4q22.1	HERC3	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
HERC3	4q22.1	HERC3	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
HERC3	4q22.1	HERC3	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
HERC5	4q22.1	HERC5	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
HERC5	4q22.1	HERC5	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
HERC5	4q22.1	HERC5	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
HERC5	4q22.1	HERC5	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
HERC5	4q22.1	HERC5	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
HERC6	4q22.1	HERC6	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
HERC6	4q22.1	HERC6	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
HERC6	4q22.1	HERC6	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
HERC6	4q22.1	HERC6	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
HERC6	4q22.1	HERC6	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
LOC644248	4q22	LOC644248	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
LOC644248	4q22	LOC644248	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
LOC644248	4q22	LOC644248	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
LOC644248	4q22	LOC644248	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
LOC644248	4q22	LOC644248	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
MMRN1	4q22	MMRN1	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
MMRN1	4q22	MMRN1	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
MMRN1	4q22	MMRN1	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
MMRN1	4q22	MMRN1	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
MMRN1	4q22	MMRN1	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
NAP1L5	4q22.1	NAP1L5	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
NAP1L5	4q22.1	NAP1L5	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
NAP1L5	4q22.1	NAP1L5	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
NAP1L5	4q22.1	NAP1L5	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
NAP1L5	4q22.1	NAP1L5	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
PIGY	4q22.1	PIGY	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
PIGY	4q22.1	PIGY	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
PIGY	4q22.1	PIGY	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
PIGY	4q22.1	PIGY	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
PIGY	4q22.1	PIGY	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
PKD2	4q22.1	PKD2	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
PKD2	4q22.1	PKD2	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
PKD2	4q22.1	PKD2	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
PKD2	4q22.1	PKD2	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
PKD2	4q22.1	PKD2	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
PPM1K	4q22.1	PPM1K	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
PPM1K	4q22.1	PPM1K	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
PPM1K	4q22.1	PPM1K	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
PPM1K	4q22.1	PPM1K	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
PPM1K	4q22.1	PPM1K	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
PYURF	4q22.1	PYURF	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
PYURF	4q22.1	PYURF	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
PYURF	4q22.1	PYURF	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
PYURF	4q22.1	PYURF	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
PYURF	4q22.1	PYURF	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
SMARCAD1	4q22	SMARCAD1	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
SMARCAD1	4q22	SMARCAD1	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
SMARCAD1	4q22	SMARCAD1	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
SMARCAD1	4q22	SMARCAD1	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
SMARCAD1	4q22	SMARCAD1	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
SPP1	4q22.1	SPP1	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
SPP1	4q22.1	SPP1	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
SPP1	4q22.1	SPP1	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
SPP1	4q22.1	SPP1	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
SPP1	4q22.1	SPP1	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
TIGD2	4q22	TIGD2	duplication	U	patientII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
TIGD2	4q22	TIGD2	duplication	U	patient III:1	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	U	N	U	EOPD	U	pedigree
TIGD2	4q22	TIGD2	duplication	U	patients I:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
TIGD2	4q22	TIGD2	duplication	U	patients I:2	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	U	N	U	EOPD	U	pedigree
TIGD2	4q22	TIGD2	duplication	U	patientIII:3	25003242	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	38	N	U	EOPD	U	pedigree
PRKN	6q26	Exon1 	deletion	heterozygous	25045378-1	25045378	RT-PCR	Korea	Asian	F	17	U	U	U	U	sporadic
PRKN	6q26	Exon1 	deletion	heterozygous	25045378-2	25045378	RT-PCR	Korea	Asian	M	35	U	U	U	U	sporadic
PRKN	6q26	Exon1 	deletion	heterozygous	25045378-3	25045378	RT-PCR	Korea	Asian	M	26	U	U	U	U	pedigree
PRKN	6q26	Exon1 	deletion	heterozygous	25045378-4	25045378	RT-PCR	Korea	Asian	M	23	U	U	U	U	pedigree
PRKN	6q26	Exon1 	deletion	heterozygous	25045378-5	25045378	RT-PCR	Korea	Asian	F	32	U	U	U	U	pedigree
PRKN	6q26	Exon2 	deletion	heterozygous	25045378-6	25045378	RT-PCR	Korea	Asian	M	36	U	U	U	U	sporadic
PRKN	6q26	Exon2	duplication	heterozygous	25045378-7	25045378	RT-PCR	Korea	Asian	F	45	U	U	U	U	pedigree
PRKN	6q26	Exon3 	deletion	heterozygous	25045378-8	25045378	RT-PCR	Korea	Asian	F	28	U	U	U	U	pedigree
PRKN	6q26	Exon4 	deletion	heterozygous	25045378-9	25045378	RT-PCR	Korea	Asian	F	25	U	U	U	U	sporadic
PRKN	6q26	Exon4 	deletion	heterozygous	25045378-10	25045378	RT-PCR	Korea	Asian	M	29	U	U	U	U	pedigree
PRKN	6q26	Exon5	duplication	heterozygous	25045378-11	25045378	RT-PCR	Korea	Asian	F	15	U	U	U	U	sporadic
PRKN	6q26	Exon6 	deletion	heterozygous	25045378-12	25045378	RT-PCR	Korea	Asian	F	36	U	U	U	U	pedigree
PRKN	6q26	Exon7 	deletion	heterozygous	25045378-13	25045378	RT-PCR	Korea	Asian	F	23	U	U	U	U	pedigree
PRKN	6q26	Exon10 	deletion	Homozygous	25045378-14	25045378	RT-PCR	Korea	Asian	M	41	U	U	U	U	sporadic
PRKN	6q26	Exon11 	deletion	Homozygous	25045378-15	25045378	RT-PCR	Korea	Asian	F	6	U	U	U	U	sporadic
PRKN	6q26	Exon4 	deletion	Homozygous	25045378-16	25045378	RT-PCR	Korea	Asian	F	30	U	U	U	U	pedigree
PRKN	6q26	Exon2	deletion	heterozygous	25045378-17	25045378	RT-PCR	Korea	Asian	M	28	U	U	U	U	sporadic
PRKN	6q26	Exon4 	deletion	heterozygous	25045378-17	25045378	RT-PCR	Korea	Asian	M	28	U	U	U	U	sporadic
PRKN	6q26	Exon7-10	deletion	heterozygous	25045378-18	25045378	RT-PCR	Korea	Asian	F	41.5	U	U	U	U	pedigree
PRKN	6q26	Exon8-10 	deletion	heterozygous	25045378-18	25045378	RT-PCR	Korea	Asian	F	41.5	U	U	U	U	pedigree
PRKN	6q26	Exon1-4 	deletion	heterozygous	25045378-19	25045378	RT-PCR	Korea	Asian	M	16	U	U	U	U	sporadic
PRKN	6q26	Exon7	duplication	heterozygous	25045378-20	25045378	RT-PCR	Korea	Asian	F	12	U	U	U	U	sporadic
PRKN	6q26	Exon2-3 	deletion	heterozygous	25045378-22	25045378	RT-PCR	Korea	Asian	M	42	U	U	U	U	pedigree
PRKN	6q26	Exon1 	deletion	heterozygous	25238391-9	25238391	MLPA	Czechia	European	U	U	U	U	U	U	sporadic
PRKN	6q26	Exon2 	deletion	heterozygous	25238391-10	25238391	MLPA	Czechia	European	U	U	U	U	U	U	sporadic
PRKN	6q26	Exon3 	deletion	heterozygous	25238391-11	25238391	MLPA	Czechia	European	U	U	U	U	U	U	sporadic
PRKN	6q26	Exon4 	deletion	heterozygous	25238391-12	25238391	MLPA	Czechia	European	U	U	U	U	U	U	sporadic
PRKN	6q26	Exon4 	deletion	Homozygous	25238391-13	25238391	MLPA	Czechia	European	U	U	U	U	U	U	sporadic
PRKN	6q26	Exon5 	deletion	heterozygous	25238391-14	25238391	MLPA	Czechia	European	U	U	U	U	U	U	sporadic
SNCA	4q22.1	Exon 2-7	triplication	U	IV-5	26077166	"Genome-wide SNP microar- rays, FISH, MLPA"	Italy	Italian	F	42	N	U	EOPD	U	pedigree
SNCA	4q22.1	Exon 2-7	triplication	U	IV-6	26077166	"Genome-wide SNP microar- rays, FISH, MLPA"	Italy	Italian	M	28	N	U	EOPD	U	pedigree
SNCA	4q22.1	Exon 2-7	triplication	U	II-4	26077167	"Genome-wide SNP microar- rays, FISH, MLPA"	Italy	Italian	F	30	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	II-4	26350119	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	71	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	III-1	26350119	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	F	61	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	IV-1	26350119	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	39	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	B-1	26350119	"Microsatellite markers analysis, qPCR, FISH, aCGH"	Japan	Japanese	M	47	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	III-3	26350119	"Microsatellite markers analysis, qPCR, FISH, aCGH"	British	British	F	38	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	duplication	U	26350119-1	26350119	"Microsatellite markers analysis, qPCR, FISH, aCGH"	American	American	M	28	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	triplication	U	III;2	26635992	"CGH-Array, MLPA, qPCR"	Italy	Italian	F	43	N	U	EOPD	U	pedigree
SNCA	4q22.1	SNCA	triplication	U	III;3	26635993	"CGH-Array, MLPA, qPCR"	Italy	Italian	M	28	N	U	EOPD	U	pedigree
PRKN	6q26	Exon3-6	deletion	heterozygous	1	27182553	MLPA	Portuguese	U	U	22	N	N 	U	U	pedigree
PRKN	6q26	Exon3-6	deletion	homozygous	2	27182553	MLPA	Portuguese	U	U	28	N	N 	U	U	sporadic
PRKN	6q26	Exon4-7	deletion	homozygous	5	27182553	MLPA	Portuguese	U	U	17	N	N 	U	U	sporadic
PRKN	6q26	Exon2	deletion	heterozygous	10	27182553	MLPA	Portuguese	U	U	31	N	N 	U	U	sporadic
PRKN	6q26	Exon3	deletion	heterozygous	13	27182553	MLPA	Portuguese	U	U	28	N	N 	U	U	sporadic
PRKN	6q26	Exon5-6	deletion	homozygous	14	27182553	MLPA	Portuguese	U	U	29	N	N 	U	U	sporadic
PRKN	6q26	Exon3-6	deletion	homozygous	17	27182553	MLPA	Portuguese	U	U	17	N	N 	U	U	pedigree
PRKN	6q26	Exon10	deletion	homozygous	20	27182553	MLPA	Portuguese	U	U	34	N	N 	U	U	sporadic
PRKN	6q26	Exon7-9	deletion	heterozygous	21	27182553	MLPA	Portuguese	U	U	23	N	N 	U	U	pedigree
PRKN	6q26	Exon4	deletion	heterozygous	22	27182553	MLPA	Portuguese	U	U	51	N	N 	U	U	sporadic
PRKN	6q26	Exon2	deletion	heterozygous	24	27182553	MLPA	Portuguese	U	U	30	N	N 	U	U	pedigree
PRKN	6q26	Exon4	deletion	homozygous	25	27182553	MLPA	Portuguese	U	U	24	N	N 	U	U	sporadic
PRKN	6q26	Exon4	deletion	heterozygous	30	27182553	MLPA	Portuguese	U	U	39	N	N 	U	U	sporadic
PRKN	6q26	Exon3-6	deletion	heterozygous	31	27182553	MLPA	Portuguese	U	U	50	N	N 	U	U	pedigree
PRKN	6q26	Exon4	deletion	homozygous	33	27182553	MLPA	Portuguese	U	U	38	N	N 	U	U	sporadic
PRKN	6q26	Exon4	deletion	heterozygous	38	27182553	MLPA	Portuguese	U	U	55	N	N 	U	U	sporadic
PRKN	6q26	Exon4-6	deletion	heterozygous	40	27182553	MLPA	Portuguese	U	U	44	N	N 	U	U	pedigree
PRKN	6q26	Exon 4	deletion	Heterozygous	4	27245731	multiplex ligation-dependent probe amplification	South African	U	F	50	U	U	typical PD	Parkinson's disease	sporadic
PRKN	6q26	Exon8-12 	deletion	heterozygous	27798970-6	27798970	Sanger Sequencing	Russia	Asia	U	U	N 	U 	U 	U 	sporadic
PARK7	1p36.22	Exon4 	deletion	Heterozygous	28124432-14	28124432	Targeted resequencing 	Yugoslavia	Europe	U	U	N	U	U	U	sporadic
PRKN	6q26	Exon3-4	deletion	Heterozygous	28124432-3	28124432	Targeted resequencing 	Yugoslavia	Europe	U	U	N	U	U	U	sporadic
PRKN	6q26	Exon2 	deletion	Heterozygous	28124432-4	28124432	Targeted resequencing 	Yugoslavia	Europe	U	U	N	U	U	U	sporadic
PRKN	6q26	Exon2-4 	deletion	Heterozygous	28124432-7	28124432	Targeted resequencing 	Yugoslavia	Europe	U	U	N	U	U	U	sporadic
PRKN	6q26	Exon3-6 	deletion	Heterozygous	28124432-8	28124432	Targeted resequencing 	Yugoslavia	Europe	U	U	N	U	U	U	sporadic
PRKN	6q26	Exon3	dup	Heterozygous	28124432-9	28124432	Targeted resequencing 	Yugoslavia	Europe	U	U	N	U	U	U	sporadic
PRKN	6q26	Exon3-7 	deletion	U	28502045-40	28502045	Sanger Sequencing	Iranian	Asia	M	12	N	U	EOPD	" First symptom:Bradykinesia;Tremor:Rest,limbs; Progression:Fast;Rigidity;Dystonia;Bradykinesia ;Hypokinesia;Response to levodopa;impaired smell"	pedigree
PRKN	6q26	Exon5-7 	deletion	U	28502045-44	28502045	Sanger Sequencing	Iranian	Asia	M	15	N	U	EOPD	" First symptom:Bradykinesia;Tremor:Rest,limbs; Progression:Fast;Rigidity;Dystonia;Bradykinesia;Hypokinesia;Response to levodopa;Wheelchair dependency"	pedigree
PRKN	6q26	Exon5-6 	deletion	U	28502045-35	28502045	Sanger Sequencing	Iranian	Asia	M	22	N	U	EOPD	" First symptom:Bradykinesia;Tremor:Rest,limbs; Progression:Slow;Rigidity;Bradykinesia ;Hypokinesia;Autonomic dysfunction;Stride and sleep apnea ;REM sleep behavior disorder ;Falling;Response to levodopa; Incontinence, depression, suicidal attempt, drug induced dyskinesias,insomnia, impaired smell"	pedigree
PRKN	6q26	Exon3-7 	deletion	U	28502045-39	28502045	Sanger Sequencing	Iranian	Asia	F	14	N	U	EOPD	" First symptom:Bradykinesia;Tremor:Rest,limbs; Progression:Slow;Rigidity;Dystonia;Bradykinesia ;Hypokinesia;Response to levodopa;impaired smell"	pedigree
PRKN	6q26	Exon5-7 	deletion	U	28502045-43	28502045	Sanger Sequencing	Iranian	Asia	M	14	N	U	EOPD	" First symptom:Bradykinesia;Tremor:Rest,limbs; Progression:Slow;Rigidity;Dystonia;Bradykinesia;Response to levodopa;impaired smell"	pedigree
PRKN	6q26	Exon5-6 	deletion	U	28502045-36	28502045	Sanger Sequencing	Iranian	Asia	M	22	N	U	EOPD	" First symptom:Slowness;Tremor:Rest; Progression:Slow;Rigidity;Dystonia;Bradykinesia ;Hypokinesia;Response to levodopa;Psychosis, dyskinesias, insomnia"	pedigree
PRKN	6q26	Exon4 	deletion	U	28502045-28	28502045	Sanger Sequencing	Iranian	Asia	M	37	N	U	EOPD	 Start location: Left upper limb; First symptom:Myoclonus; Progression Moderate;Rigidity;Bradykinesia ;HypokinesiaResponse to levodopa; Off dystonia	pedigree
PRKN	6q26	Exon5-6 	deletion	U	28502045-18	28502045	Sanger Sequencing	Iranian	Asia	F	17	N	U	EOPD	" Start location:Hands; First symptom: Resting tremor; Tremor:  intention, limbs; Progression Fast;Bradykinesia ;Hypokinesia;Falling;Amnesia;Insomnia"	pedigree
PRKN	6q26	Exon5-6 	deletion	U	28502045-17	28502045	Sanger Sequencing	Iranian	Asia	F	34	N	U	EOPD	" Start location:Hands; First symptom: Resting tremor; Tremor:  intention, limbs; Progression Slow;Rigidty;Autonomic dysfunction;Pyramidal signs:spasticity;"	pedigree
PRKN	6q26	Exon5 	deletion	U	28502045-31	28502045	Sanger Sequencing	Iranian	Asia	F	45	N	U	EOPD	" Start location:Hands; First symptom:Resting tremor;Tremor:Rest,limbs; Progression:Slow;Rigidity;Dystonia;Response to levodopa;Insomnia "	pedigree
PRKN	6q26	Exon5 	deletion	U	28502045-32	28502045	Sanger Sequencing	Iranian	Asia	F	45	N	U	EOPD	 Start location:Hands; First symptom:Resting tremor;Tremor:Rest; Progression:Slow;Rigidity;Dystonia;Bradykinesia;Falling;Response to levodopa;	pedigree
PRKN	6q26	Exon3 	deletion	U	28502045-26	28502045	Sanger Sequencing	Iranian	Asia	M	30	N	U	EOPD	" Start location:Left hand; First symptom: Resting tremor; Tremor:Rest, intention, limbs; Progression Fast;Rigidity;Autonomic dysfunction;Response to levodopa"	pedigree
PRKN	6q26	Exon3-4 	deletion	U	28502045-24	28502045	Sanger Sequencing	Iranian	Asia	M	27	N	U	EOPD	" Start location:Left leg; First symptom: Resting tremor; Tremor:limbs; Progression Slow;Bradykinesia ;Hypokinesia;Autonomic dysfunction;Pyramidal signs:spasticity;Falling;Response to levodopa;   Incontinence, wheelchair dependency, insomnia, seizure, impaired smell"	pedigree
PRKN	6q26	Exon3 	deletion	U	28502045-15	28502045	Sanger Sequencing	Iranian	Asia	F	23	N	U	EOPD	" Start location:Leg; First symptom: Resting tremor; Tremor: Limbs, voice; Progression Slow;Rigidity;Bradykinesia ;Hypokinesia;Autonomic dysfunction;Pyramidal signs:spasticity;Stride and sleep apnea;Response to levodopa;Amnesia"	pedigree
PRKN	6q26	Exon3 	deletion	U	28502045-14	28502045	Sanger Sequencing	Iranian	Asia	M	24	N	U	EOPD	" Start location:Leg; First symptom: Resting tremor; Tremor:Limbs, head, neck; Progression Fast;Bradykinesia ;Hypokinesia;Stride and sleep apnea;Response to levodopa;Sensory polyneuropathy"	pedigree
PRKN	6q26	Exon3 	deletion	U	28502045-25	28502045	Sanger Sequencing	Iranian	Asia	F	28	N	U	EOPD	" Start location:legs; First symptom: Resting tremor; Tremor:Rest, intention, limbs; Progression Fast;Autonomic dysfunction;Stride and sleep apnea;Response to levodopa;Amnesia"	pedigree
PRKN	6q26	Exon4 	deletion	U	28502045-27	28502045	Sanger Sequencing	Iranian	Asia	M	44	N	U	EOPD	" Start location:legs; First symptom: Resting tremor; Tremor:Rest; Progression Fast;Rigidity;Bradykinesia ;Hypokinesia;Autonomic dysfunction;Pyramidal signs:spasticity; Stride and sleep apnea ;REM sleep behavior disorder;Response to levodopa;Incontinence, amnesia, insomnia, seizure"	pedigree
PRKN	6q26	Exon7 	deletion	U	28502045-29	28502045	Sanger Sequencing	Iranian	Asia	F	27	N	U	EOPD	 Start location:Legs; First symptom:Resting tremor;Tremor:Rest; Progression:Slow;Dystonia;Bradykinesia ;Response to levodopa	pedigree
PRKN	6q26	Exon7 	deletion	U	28502045-30	28502045	Sanger Sequencing	Iranian	Asia	F	35	N	U	EOPD	 Start location:Legs; First symptom:Resting tremor;Tremor:Rest; Progression:Slow;Falling;Response to levodopa; Insomnia	pedigree
PRKN	6q26	Exon3 	deletion	U	28502045-16	28502045	Sanger Sequencing	Iranian	Asia	F	27	N	U	EOPD	" Start location:Limbs; First symptom: Resting tremor; Tremor: Rest, intention, limbs, chin, voice; Progression Slow;Autonomic dysfunction;Stride and sleep apnea;Falling;Response to levodopa;Insomnia"	pedigree
PRKN	6q26	Exon5 	deletion	U	28502045-20	28502045	Sanger Sequencing	Iranian	Asia	M	23	N	U	EOPD	" Start location:Limbs; First symptom: Resting tremor; Tremor: Rest, limbs, head, chin; Progression Slow;Rigidity;Bradykinesia ;Hypokinesia;Autonomic dysfunction;Pyramidal signs:spasticity; Stride and sleep apnea ;REM sleep behavior disorder;Falling;Response to levodopa; Incontinence, wheelchair dependency, insomnia, impaired smell"	pedigree
PRKN	6q26	Exon5 	deletion	U	28502045-21	28502045	Sanger Sequencing	Iranian	Asia	M	24	N	U	EOPD	" Start location:Limbs; First symptom: Resting tremor; Tremor: Rest, limbs, head, chin; Progression Slow;Rigidity;Bradykinesia ;Hypokinesia;Autonomic dysfunction;Pyramidal signs:spasticity; Stride and sleep apnea ;REM sleep behavior disorder;Falling;Response to levodopa; Incontinence, wheelchair dependency, insomnia, impaired smell"	pedigree
PRKN	6q26	Exon5 	deletion	U	28502045-22	28502045	Sanger Sequencing	Iranian	Asia	F	35	N	U	EOPD	" Start location:Limbs; First symptom: Resting tremor; Tremor: Rest, limbs, head, chin; Progression Slow;Rigidity;Bradykinesia ;Hypokinesia;Autonomic dysfunction;Pyramidal signs:spasticity; Stride and sleep apnea ;REM sleep behavior disorder;Falling;Response to levodopa; Incontinence, wheelchair dependency, insomnia, impaired smell"	pedigree
PRKN	6q26	Exon3-4 	deletion	U	28502045-23	28502045	Sanger Sequencing	Iranian	Asia	F	27	N	U	EOPD	" Start location:Limbs; First symptom: Resting tremor; Tremor: Rest, limbs; Progression Slow;Bradykinesia ;Hypokinesia;Autonomic dysfunction;Falling;Response to levodopa;  Amnesia, insomnia"	pedigree
PRKN	6q26	Exon5 	deletion	U	28502045-12	28502045	Sanger Sequencing	Iranian	Asia	M	13	N	U	EOPD	" Start location:Limbs; First symptom: Resting tremor; Tremor:Intention, limbs, chin; Progression Slow;Bradykinesia ;Hypokinesia;Autonomic dysfunction;Falling  Response to levodopa;Eyelid apraxia or blepharospasm, incontinence, sensory;polyneuropathy, impaired smell"	pedigree
PRKN	6q26	Exon5-6 	deletion	U	28502045-19	28502045	Sanger Sequencing	Iranian	Asia	M	20	N	U	EOPD	" Start location:Whole body; First symptom: Whole body tremor; Tremor:Rest, intention, limbs,voice; Progression Fast;Rigidity;Autonomic dysfunction;Pyramidal signs:spasticity;Stride and sleep apnea;REM sleep behavior disorder;Faling;Response to levodopa;Amnesia, insomnia, seizure"	pedigree
PRKN	6q26	Exon5 	deletion	U	28502045-13	28502045	Sanger Sequencing	Iranian	Asia	M	13	N	U	EOPD	" Start location:Whole body; First symptom: Whole body tremor; Tremor:Rest, intention, limbs; Progression Slow;Rigidity;Bradykinesia ;Hypokinesia;Response to levodopa;Sensory polyneuropathy"	pedigree
PRKN	6q26	Exon5 	deletion	U	28502045-11	28502045	Sanger Sequencing	Iranian	Asia	M	13	N	U	EOPD	"Bradykinesia ;Hypokinesia;Autonomic dysfunction;Falling  Response to levodopa;Eyelid apraxia or blepharospasm, incontinence, sensory;polyneuropathy, impaired smell"	pedigree
PRKN	6q26	Exon3 	deletion	U	28502045-49	28502045	Sanger Sequencing	Iranian	Asia	M	23	N	U	EOPD	First symptom:Bradykinesia;Progression:slow;Rigidity;Dystonia;Bradykinesia;Falling;Response to levodopa; 	pedigree
PRKN	6q26	Exon9  	deletion	U	28502045-46	28502045	Sanger Sequencing	Iranian	Asia	M	24	N	U	EOPD	"First symptom:Bradykinesia;Tremor: Intention, limbs, chin, voice; Progression:fast;Rigidity;Dystonia;Bradykinesia;Hypokinesia;Autonomic dysfunction;Pyramidal signs:spasticity;REM sleep behavior disorder ;Falling;Response to levodopa;  Eyelid apraxia or blepharospasm, wheelchair dependency, psychosis,amnesia, insomnia, seizure, impaired smell"	pedigree
PRKN	6q26	Exon3 	deletion	U	28502045-50	28502045	Sanger Sequencing	Iranian	Asia	M	24	N	U	EOPD	start location:Hands;First symptom:Resting tremor;tremor:Rest;Progression:slow;Rigidity;Bradykinesia;Falling;Response to levodopa; 	pedigree
PRKN	6q26	Exon9  	deletion	U	28502045-45	28502045	Sanger Sequencing	Iranian	Asia	F	25	N	U	EOPD	"start location:Left hand; First symptom:Resting tremor;Tremor: Intention, limbs, head, voice; Progression:slow;Rigidity;Dystonia;Bradykinesia;Hypokinesia;Autonomic dysfunction;Pyramidal signs:spasticity;REM sleep behavior disorder ;Falling;Response to levodopa; Eyelid apraxia or blepharospasm, psychosis, amnesia, insomnia,seizure, impaired smell"	pedigree
PRKN	6q26	Exon3 	deletion	U	28502045-47	28502045	Sanger Sequencing	Iranian	Asia	M	30	N	U	EOPD	"start location:Left hand; First symptom:Resting tremor;Tremor: Intention, limbs, voice; Progression:Fast;Bradykinesia;Hypokinesia;Autonomic dysfunction;Pyramidal signs:spasticity;Falling;Response to levodopa;Incontinence, insomnia, impaired smell"	pedigree
PRKN	6q26	Exon3 	deletion	U	28502045-48	28502045	Sanger Sequencing	Iranian	Asia	M	21	N	U	EOPD	"start location:Whole body; First symptom:Resting tremor;Tremor: Intention, limbs,chin, voice; Progression:Fast;rigidity;Bradykinesia;Hypokinesia;Autonomic dysfunction;Pyramidal signs:spasticity;Falling;Response to levodopa;insomnia, impaired smell"	pedigree
PRKN	6q26	Exon3-4	deletion	U	28862745-3	28862745	whole exome sequencing	European	Caucasian	M	39	N	N 	EOPD	U	sporadic
PRKN	6q26	Exon4 	deletion	heterozygous	28913705-9	28913705	Sanger sequencing	Arab	Asia	M	46	N	U	EOPD	"Instability, stiffness"	pedigree
PRKN	6q26	Exon4 	deletion	heterozygous	28913705-10	28913705	Sanger sequencing	Arab	Asia	M	NA	N	U	EOPD	"Instability, stiffness, bradykinesia"	pedigree
PRKN	6q26	Exon4 	deletion	heterozygous	28913705-11	28913705	Sanger sequencing	Arab	Asia	M	29	N	U	EOPD	"Instability, stiffness, bradykinesia"	pedigree
PRKN	6q26	Exon4 	deletion	heterozygous	28913705-7	28913705	Sanger sequencing	Arab	Asia	M	46	N	U	EOPD	"Tremor, walking difficulties, weakness"	pedigree
PRKN	6q26	Exon4 	deletion	heterozygous	28913705-8	28913705	Sanger sequencing	Arab	Asia	M	41	N	U	EOPD	"Weakness, falls"	pedigree
PRKN	6q26	Exon9 	deletion	homozygous	3158	29163333	Chromosomal microarray analysis 	Morocco	Asia	M	43	N	U	JOPD 	"Bradykinesia ,Resting tremor ,Akinesia ,Rigidity , Gait impairment ,Postural instability , UPDRS III:14,H-Y score :1,Levodopa equivalent dose:300,Urinary dysfunction ,Orthostatic HypoTA ,Constipation ,Cognitive decline "	pedigree
PRKN	6q26	Exon6-7	deletion	homozygous	3468	29163333	Chromosomal microarray analysis 	Morocco	Asia	M	39	N	U	JOPD 	"Resting tremor ,Akinesia ,Gait impairment , UPDRS III:20,H-Y score :2,Levodopa equivalent dose:150,Urinary dysfunction"	pedigree
PRKN	6q26	Exon3-7 	deletion	heterozygous	3020	29163333	Chromosomal microarray analysis 	Morocco	Asia	M	17	N	U	EOPD 	"Resting tremor ,Akinesia ,Rigidity ,Dystonia, Gait impairment , UPDRS III:15,H-Y score :3,,Levodopa equivalent dose:Artane 5 mg 4cp/j "	pedigree
PRKN	6q26	Exon2 	deletion	heterozygous	29248340-8	29248340	MLPA	Turkey	Asia and Europe	M	40	N	U	EOPD	with unilateral tremor followed by bradykinesia and rigidity. The symptoms have beenslowly progressive since and still respond well to levodopa	sporadic
SNCA	4q22.1	SNCA	duplication	Heterozygous	29248340-6	29248340	MLPA	Turkey	Asia and Europe	F	46	N	U	YOPD	U	sporadic
SNCA	4q22.1	SNCA	duplication	Heterozygous	29248340-7	29248340	MLPA	Turkey	Asia and Europe	M	41	N	U	YOPD	U	sporadic
PRKN	6q26	Exon6 	deletion	heterozygous	29353703-2	29353703	Sanger Sequencing	U	U	F	33	Y	Y	EOPD	U	sporadic
PRKN	6q26	Exon6 	deletion	heterozygous	29353703-2	29353703	Sanger sequencing	U	U	U	78	N	U	LOPD	U	sporadic
PRKN	6q26	Exon1-2	deletion	heterozygous	29568695-2	29568695	Sanger sequencing 	China	Asia	F	24	N	U	EOPD	Sensitivity to dopamine;Resting tremor;Myotonia;Bradykinesia;Posture balancedisturbance	pedigree
PRKN	6q26	Exon1-2	deletion	heterozygous	29568695-3	29568695	Sanger sequencing 	China	Asia	M	U	N	U	EOPD	Sensitivity to dopamine;Resting tremor;Myotonia;Bradykinesia;Posture balancedisturbance	pedigree
PRKN	6q26	Exon1-2	deletion	heterozygous	29568695-4	29568695	Sanger sequencing 	China	Asia	M	U	N	U	EOPD	Sensitivity to dopamine;Resting tremor;Myotonia;Bradykinesia;Posture balancedisturbance	pedigree
PACRG	6q26	Exon 1-2	deletion	Heterozygous	29577677-2	29577677	CMA，FISH	U	U	M	20	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 1	deletion	Heterozygous	29577677-1	29577677	CMA，FISH	U	U	M	20	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 3	deletion	Heterozygous	29577677-3	29577677	CMA，FISH	U	U	M	20	N	U	EOPD	U	pedigree
PRKN	6q26	Exon 2-3	deletion	U	30099245-1	30099245	"Sanger,MLPA"	Serbian	Serbian	F	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2-3	deletion	U	30099245-1	30099245	"Sanger,MLPA"	Serbian	Serbian	M	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3-4	duplication	U	30099245-2	30099245	"Sanger,MLPA"	Serbian	Serbian	F	U	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3-4	duplication	U	30099245-2	30099245	"Sanger,MLPA"	Serbian	Serbian	M	U	N	U	EOPD	U	sporadic
SNCA	4q22.1	SNCA	Duplication	U	23880019-1	23880019	"MLPA, qPCR"	Iranian	Iranian	U	38	N	U	EOPD	U	sporadic
SNCA	4q22.1	SNCA	Triplication	U	23880019-2	23880019	"MLPA, qPCR"	Iranian	Iranian	U	26	N	U	EOPD	U	sporadic
PINK1	1p36.12	Exon 2-4	Deletion	heterozygous	23880019-3	23880019	"MLPA, qPCR"	Iranian	Iranian	U	25	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-4	23880019	"MLPA, qPCR"	Iranian	Iranian	U	25	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-5	23880019	"MLPA, qPCR"	Iranian	Iranian	U	28	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-6	23880019	"MLPA, qPCR"	Iranian	Iranian	U	31	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-7	23880019	"MLPA, qPCR"	Iranian	Iranian	U	30	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-8	23880019	"MLPA, qPCR"	Iranian	Iranian	U	26	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3	Deletion	Homozygous	23880019-9	23880019	"MLPA, qPCR"	Iranian	Iranian	U	22	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3	Deletion	Homozygous	23880019-10	23880019	"MLPA, qPCR"	Iranian	Iranian	U	18	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3	Deletion	Homozygous	23880019-11	23880019	"MLPA, qPCR"	Iranian	Iranian	U	29	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2-4	Deletion	Homozygous	23880019-12	23880019	"MLPA, qPCR"	Iranian	Iranian	U	28	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2-5	Deletion	Homozygous	23880019-13	23880019	"MLPA, qPCR"	Iranian	Iranian	U	20	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2-3	Deletion	Homozygous	23880019-14	23880019	"MLPA, qPCR"	Iranian	Iranian	U	16	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 2-4	Deletion	Homozygous	23880019-15	23880019	"MLPA, qPCR"	Iranian	Iranian	U	15	N	U	EOPD	U	sporadic
PRKN	6q26	Exon 3	Deletion	Homozygous	23880019-16	23880019	"MLPA, qPCR"	Iranian	Iranian	U	21	N	U	U	U	pedigree
PRKN	6q26	Exon 3	Deletion	Homozygous	23880019-17	23880019	"MLPA, qPCR"	Iranian	Iranian	U	21	N	U	U	U	pedigree
PRKN	6q26	Exon 3	Deletion	Homozygous	23880019-18	23880019	"MLPA, qPCR"	Iranian	Iranian	U	31	N	U	U	U	pedigree
PRKN	6q26	Exon 3	Deletion	Homozygous	23880019-19	23880019	"MLPA, qPCR"	Iranian	Iranian	U	31	N	U	U	U	pedigree
PRKN	6q26	Exon 2-12	Deletion	Homozygous	23880019-20	23880019	"MLPA, qPCR"	Iranian	Iranian	U	18	N	U	U	U	pedigree
PRKN	6q26	Exon 2-12	Deletion	Homozygous	23880019-21	23880019	"MLPA, qPCR"	Iranian	Iranian	U	18	N	U	U	U	pedigree
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-22	23880019	"MLPA, qPCR"	Iranian	Iranian	U	29	N	U	U	U	pedigree
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-23	23880019	"MLPA, qPCR"	Iranian	Iranian	U	29	N	U	U	U	pedigree
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-24	23880019	"MLPA, qPCR"	Iranian	Iranian	U	29	N	U	U	U	pedigree
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-25	23880019	"MLPA, qPCR"	Iranian	Iranian	U	31	N	U	U	U	pedigree
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-26	23880019	"MLPA, qPCR"	Iranian	Iranian	U	31	N	U	U	U	pedigree
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-27	23880019	"MLPA, qPCR"	Iranian	Iranian	U	30	N	U	U	U	pedigree
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-28	23880019	"MLPA, qPCR"	Iranian	Iranian	U	30	N	U	U	U	pedigree
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-29	23880019	"MLPA, qPCR"	Iranian	Iranian	U	28	N	U	U	U	pedigree
PRKN	6q26	Exon 2	Deletion	Homozygous	23880019-30	23880019	"MLPA, qPCR"	Iranian	Iranian	U	28	N	U	U	U	pedigree
PRKN	6q26	Exon 3-5	Deletion	Homozygous	23880019-31	23880019	"MLPA, qPCR"	Iranian	Iranian	U	25	N	U	U	U	pedigree
PRKN	6q26	Exon 3-5	Deletion	Homozygous	23880019-32	23880019	"MLPA, qPCR"	Iranian	Iranian	U	25	N	U	U	U	pedigree
PRKN	6q26	Exon 3-5	Deletion	Homozygous	23880019-33	23880019	"MLPA, qPCR"	Iranian	Iranian	U	25	N	U	U	U	pedigree
PRKN	6q26	Exon 2-4	Deletion	heterozygous	23880019-34	23880019	"MLPA, qPCR"	Iranian	Iranian	U	29	N	U	U	U	pedigree
PRKN	6q26	Exon 2-4	Deletion	heterozygous	23880019-35	23880019	"MLPA, qPCR"	Iranian	Iranian	U	29	N	U	U	U	pedigree
PRKN	6q26	Exon 2-4	Deletion	heterozygous	23880019-36	23880019	"MLPA, qPCR"	Iranian	Iranian	U	29	N	U	U	U	pedigree
PRKN	6q26	Exon 2-3	Deletion	heterozygous	23880019-37	23880019	"MLPA, qPCR"	Iranian	Iranian	U	30	N	U	U	U	pedigree
PRKN	6q26	Exon 2-3	Deletion	heterozygous	23880019-38	23880019	"MLPA, qPCR"	Iranian	Iranian	U	30	N	U	U	U	pedigree
PRKN	6q26	Exon 2-3	Deletion	heterozygous	23880019-39	23880019	"MLPA, qPCR"	Iranian	Iranian	U	30	N	U	U	U	pedigree
PRKN	6q26	Exon 2-3	Deletion	heterozygous	23880019-40	23880019	"MLPA, qPCR"	Iranian	Iranian	U	30	N	U	U	U	pedigree
PRKN	6q26	Exon 2-4	Deletion	heterozygous	23880019-41	23880019	"MLPA, qPCR"	Iranian	Iranian	U	14	N	U	U	U	pedigree
PRKN	6q26	Exon 2-4	Deletion	heterozygous	23880019-42	23880019	"MLPA, qPCR"	Iranian	Iranian	U	14	N	U	U	U	pedigree
PARK7	1p36.22	Exon 5	deletion	Homozygous	23880019-43	23880019	"MLPA, qPCR"	Iranian	Iranian	U	36	N	U	U	U	pedigree
PARK7	1p36.22	Exon 5	deletion	Homozygous	23880019-44	23880019	"MLPA, qPCR"	Iranian	Iranian	U	36	N	U	U	U	pedigree
PARK7	1p36.22	Exon 5	deletion	Homozygous	23880019-45	23880019	"MLPA, qPCR"	Iranian	Iranian	U	36	N	U	U	U	pedigree
PINK1	1p36.12	Exon 5	Deletion	Homozygous	23880019-46	23880019	"MLPA, qPCR"	Iranian	Iranian	U	42	N	U	U	U	pedigree
PINK1	1p36.12	Exon 5	deletion	Homozygous	23880019-47	23880019	"MLPA, qPCR"	Iranian	Iranian	U	42	N	U	U	U	pedigree
PINK1	1p36.12	Exon 5	Deletion	Homozygous	23880019-48	23880019	"MLPA, qPCR"	Iranian	Iranian	U	42	N	U	U	U	pedigree
PINK1	1p36.12	Exon 4	deletion	Homozygous	23880019-49	23880019	"MLPA, qPCR"	Iranian	Iranian	U	38	N	U	U	U	pedigree
PINK1	1p36.12	Exon 4	Deletion	Homozygous	23880019-50	23880019	"MLPA, qPCR"	Iranian	Iranian	U	38	N	U	U	U	pedigree
PINK1	1p36.12	Exon 4	Deletion	Homozygous	23880019-51	23880019	"MLPA, qPCR"	Iranian	Iranian	U	38	N	U	U	U	pedigree
ATP13A2	1p36.13	Exon 2	Deletion	Homozygous	23880019-52	23880019	"MLPA, qPCR"	Iranian	Iranian	U	12	N	U	U	U	pedigree
ATP13A2	1p36.13	Exon 2	Deletion	Homozygous	23880019-53	23880019	"MLPA, qPCR"	Iranian	Iranian	U	12	N	U	U	U	pedigree
ATP13A2	1p36.13	Exon 2	Deletion	Homozygous	23880019-54	23880019	"MLPA, qPCR"	Iranian	Iranian	U	12	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	Duplication	U	23880019-55	23880019	"MLPA, qPCR"	Iranian	Iranian	U	39	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	Duplication	U	23880019-56	23880019	"MLPA, qPCR"	Iranian	Iranian	U	39	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	Duplication	U	23880019-57	23880019	"MLPA, qPCR"	Iranian	Iranian	U	44	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	Duplication	U	23880019-58	23880019	"MLPA, qPCR"	Iranian	Iranian	U	44	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	Triplication	U	23880019-59	23880019	"MLPA, qPCR"	Iranian	Iranian	U	25	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	Triplication	U	23880019-60	23880019	"MLPA, qPCR"	Iranian	Iranian	U	25	N	U	U	U	pedigree
SNCA	4q22.1	SNCA	Triplication	U	23880019-61	23880019	"MLPA, qPCR"	Iranian	Iranian	U	25	N	U	U	U	pedigree
PRKN 	6q26	exon 4 	deletion	compound heterozygous 	32391545-1	32391545	WES	China	Chinese	F	24	N	U	"Rigidity,Bradykinesia,Gait disturbance,Diurnal fluctuations, Hyperreflexia,levodopa-induced dyskinesia"	EOPD	pedigree
PRKN 	6q26	exon 4 	deletion	compound heterozygous 	32391545-2	32391545	WES	China	Chinese	M	24	N	U	"Tremor,Rigidity,Bradykinesia,Hyperreflexia"	EOPD	pedigree
